Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 . . . . : . . . . 2 . ] 215
batch____ bits E-value N 100.0% 1:215 MIQTFFDFPVYFKFFIGLFALVNPVGIIPVFISMTSYQTAAARNKTNLTANLSVAIILWISLFLGDTILQLFGISIDSFRIAGGILVVTIAMSMISGKLGEDKQNKQEKSETAVRESIGVVPLALPLMAGPGAISSTIVWGTRYHSISYLFGFFVAIALFALCCWGLFRMAPWLVRVLRQTGINVITRIMGLLLMALGIEFIVTGIKGIFPGLLN
1 UniRef50_C6X9P4 Multiple antibiotic resista... 184 1e-45 1 43.5% 5:213 1:209 ----MSEWAYLFKTGIALFAIVNPVGSVPIFISATDGWSPKDRARTAKTVGLTVFVVLMTSAFLGNGILDFFSISIPSFQVGGGILVMLIAISMMHGKQSHARQTPEEAQAVAEREVIAIVPLSIPLLAGPGAISSMIITAQKHSGFWGHVSLIVPVAAVCLLIWLTLRLSSAIAHKLGTLGINIVTRLMGLILAAMAVEFIAQGISGLFPGL--
2 UniRef50_A3IQE6 Multiple antibiotic resista... 177 2e-43 1 38.2% 6:212 1:207 -----MNFSEYINSFITLLAISNPIGNLPIYLGLTADKTKKQRQQTIKTASIAFAIILIVSCFMGEVILSAFGISIASFRVAGGFLIFIFGFHMLQAKTSDIHHTSEENQDAQTADSIAIVPLALPLLAGPGTISSVIVLAHKTQSLVEKLGLSIVIIILAILIFISYSFAHVIGNFLGKTGMNIVTRLMGLITMAMAVQFMADGLEVLFPG---
3 UniRef50_C1D8X8 Probable multiple antibioti... 177 2e-43 1 41.7% 10:215 2:207 ---------EVFKIFIALLVLVNPIGAIPIFISLTPNSTAEERQRIALTTSKAVAIVTVTFALLGETILKFLNISVGSFQVGGGILMMLIAIAMMNAKQTPTKTTRQEQEEAEFKTNIAVVPLAIPLMTGPGTMSTIIIYASTSHDWIELVMLLLACGLIAVTCYVALRAATPISRMLGQTGINIVNRVMGMVLAAVSVEVIVNGLYRLFPMLNH
4 UniRef50_B6IWJ1 MarC integral membrane fami... 174 1e-42 1 39.5% 5:214 1:210 ----MEPWSEYSRFIVALFAMLTPFAAIPIFLGLTEGRTDAERNRTAASAALTVFSVLAGSAFLGNAVLAVVGTSLDSFRVGGGIVLLLIALSMLNATVSAVKQTPTEADEAASRHAIGVVPLGLPLLAGPGSISAVIIETQRGSGWEHTAIIVGSITLVCLFIWLSLRLAVPIGRMMGRTGLNIMNRLFGLLLAAVAVEIISTGLRNLFPGWT-
5 UniRef50_Q13TQ7 Multiple antibiotic resista... 174 2e-42 1 39.4% 11:213 3:205 ----------ILKSFISLLALINPVGAIPFFMSLTAHQSDAERRRTIRIAAISVFCVIAVTTLLGQQIIAFFGISVGSLEVGGGIIMLLMAINMLNAQIGNSRSTPEERHEAEQKDNIAVVPLAIPLLTGPGAISTTIIYAAGSAHWYDRISLVAIGAVLAAICFFSLRLAEPIARWVGRTGINIGTRLMGLMLSALAVEFIVDGLKALLPNL--
6 UniRef50_B5EJL1 Multiple antibiotic resista... 172 5e-42 1 36.9% 2:215 1:214 -MPVAAELHSALQTLIALLAILNPVGAIPIFIALTSDEDPQQRLATAKLASRAVAVVLLTSAFLGEYILQFFGISIAAFQVAGGMVLMLLAFNMLQAKSSRYRHTPEEAAEGMQKEAVAVVPLAIPLLAGPGTMVTVIIAHHKNASWLASGLLIIDILVIAGVAYAALRLAEPLSRRLGVTGINISTRIFGLVLAAIAVTFIANGLAALFPGLVH
7 UniRef50_D1CJ06 Multiple antibiotic resista... 171 2e-41 1 28.6% 8:213 1:207 -------MNFFLKALVALFTIVDPIGMAPIVVGLTAHLSPAVRRRVVTRATLIATGVVAVFALFGKPLLEFLGITPEAFSIAGGALLFLVSIDMLFGRESGARETGREAREARTREDISVFPLAIPLIAGPGTITTVILLMDSagHASRQLAVAAAVAIVMFCTWVSMSLAFPIQKRMGTTGTLVLSRVLGMLLAAIAIQYILNGLSSFAESL--
8 UniRef50_A3P530 MarC family integral membra... 170 3e-41 1 26.7% 8:213 196:407 -------ISEILFGFTGLMGIINPFGIAFLFLERTESLTEAQRAALARKVAINAFIVLLAAFFVGTPILHFFGISLEALRIGGGLAVAVAGWQMLnpDVPTGGDTAAQPVEPRNAMARAFFPLTIPLTTGPGSIATAIALNANRThvLSSIVSVAVSALAALVIWQTYSRAAFLARYLGTEGTKVAMRVSAFLLLCVGVQIMLTGFSEFLRPI--
9 UniRef50_B4U7Z6 Multiple antibiotic resista... 170 4e-41 1 34.1% 3:213 5:215 --QAIDIIYFIIKFSISIFAILNPFGALPVLVSLTKGYTKEDRSYVIRTSSIYAGLTLIFFVLFGDLLFEIFGIGLGAFQIGGGIILSFVSINMIFGQPHRERASNQELEEAEQKENIAIVPIAIPLLAGPGAISTVITIASSYRSVFYHVLLILSILVACIGVFLVFKSVDKIVKILGKIGINILSRLMGILLMSLAMQFIIKGIQLAFPTL--
10 UniRef50_A0B911 Multiple antibiotic resista... 169 8e-41 1 30.8% 2:215 17:229 -LDLAIYLQYFVYVFTSLFIIVSPIEATMVFVSLTQDASPAERDRICVRTTLVAFSIAMVFALAGDMILRFFGITVDSLRVAGGILLFLVAIDMLRAKP-HKKVTQAEIEDATTREDISIFPLAIPLLTGPGTITTVIVHMGASNTLPEKMIVLLAICLTFGATYAILKSAEHIHDILGVTGIMVFTRILGLILGAIAVDFVSVGAWNIYISMAS
11 UniRef50_O32244 UPF0056 membrane protein yv... 169 8e-41 1 32.4% 6:215 1:211 -----MMFSFIVHVFISLFAVSNPIGNVPIFLTLTEGYTAAERKAIARKAAILSFFILAAFLVFGHLIFKLFDINIHALRVAGGIFIFGIAYNLLNAKEShqSLHHDEHKESKEKADISVTPLSIPIIAGPGTIATVMSLSAGHSGIGHYAAVMIGIAAVIALTFLFFHYSAFISSKLGKTEMNVITRLMGLILAVVAVGMIGAGLKGMFPVLTS
12 UniRef50_Q1Q2V4 Putative uncharacterized pr... 168 1e-40 1 31.6% 5:213 1:209 ----MEHWTEYTRFLTALMVILDPFAAIPIFLSLTQGYSQSQRARVVLVTIITVALVLISSAISGESLLKTFGTSLASFRVGGGIVLFIMALAMLRAQADKVKTSPTEEAAAENKATIAVVPLAIPLLAGPGSISTVIIEMHRSSATYHGALVILCILITCILLWIVLRLASPIGRALGPIGRNILNRLFGLILTAIAIEIIANGLRELFPSL--
13 UniRef50_C5U4I6 Multiple antibiotic resista... 166 4e-40 1 32.5% 6:211 1:205 -----MDIQYFIISFTSIFSILNPIGAVPIFISLTESYPEKERILVAKKTVIYAFSILLAFAVFGEYILKFFGISIEAFKIGGGILLLLIALDMVRGK-QESKIHKREIKEADEVDEIALMPLATPLLAGPGSITAVMVAMAEAPSFEDRIFVILAILISIFITYLTFVFSERIIDKLGRLGTRILTRLMGLILTAIAVQMILTGYLGVVR----
14 UniRef50_Q1IWE7 Multiple antibiotic resista... 166 4e-40 1 29.9% 2:212 1:212 -MNVAELSSISLQTFLTMLVVMDPIGLAPIFIGLAGNRPSFERRRMALRASVVAGVIILCFGLFGRGLLDHLGISLSAFRVAGGILLFLIALDMVFARPSGSKETPEEGQEAQERQDISVFPLAIPLIAGPGTLASIMILAGDAHGNPALlaVFVVTFLVLLLCYLALRLSGQIARVIGVTGVHVVTRVLGVLLGALAVQYVADGALEFLRG---
15 UniRef50_Q58382 UPF0056 membrane protein MJ... 165 1e-39 1 32.4% 1:210 13:222 VVKYMDILNFYIYGFVSLFITIDPIGLIPIVHSLTYPYPKEQRIRIIKKAIISSTVVLLLFALFGNYIFGYFGITIDAFRVAGGILLFKIAWDMLHAEIPKTKHKPDERLDLEDIDSIVYVPLAIPLISGPGAITTTMILISKTQSILEKGVVVLSILSAMLVSGIILSLTDFIIRRVNIYGINAFVRIMGLLLVAISVQIIFTGIVGLY-----
16 UniRef50_O66819 UPF0056 membrane protein aq... 165 1e-39 1 32.2% 10:211 12:213 ---------LFVKAFLSLLAIMNPFSSVPVVISLMNEYSKEEIRVIALKASVYAFFILTFFLISGDLLFRFMGITLPAFKVGGGILLFLIALNLVQGEVTKEKGKAHEIEAALRRDNIALIPLAMPLLAGPGSITTVLVLRGYLNTLEGKVALFCAIFLSSFTAFVVYSLSTFFYRVLGRTGINLITRISGILLLAISVQFVVDGLKNLLK----
17 UniRef50_B9XPN0 Multiple antibiotic resista... 164 2e-39 1 30.0% 5:214 1:210 ----MSLFEYTLLAGSSLFVIVDPVATVPAFIAMTPHDTPEQRIKTARLACFVMAGVLLSFAAAGRVIFKLMGITMPAFQIAASIVLLLVALDMLRAQRSRVQETHEETEAGAEKADIAVTPLAIPMLAGPGAISTAILLQNQAKTAAQHAAVYVCILGVSFASYLILKVSARGAKWLNPIAMNVAIRIMGLLLAAVAIQFGLNAFKTLRTDLL-
18 UniRef50_C1CXZ5 Putative multiple antibioti... 164 3e-39 1 32.2% 8:215 8:216 -------LTTINKTFLTMLVVMDPIGLAPIFIGLASNRPRFERQRVAFKATLVAGIIILMFGLFGRDLLKHLGISLSAFRIAGGVLLFMIALDMVFARPSGSKETPEEEQEAHERQDISVFPLAIPLIAGPGTLASIMILAGDAHGEPLLLGGVFSvfLVLLLCYLALRLSGQIARVIGLTGVHVVTRVLGVLLGALAVQYIADGTLELLRGGLK
19 UniRef50_Q2IJJ0 Multiple antibiotic resista... 163 3e-39 1 27.1% 8:214 5:209 -------LDYGLLVFVSMFTMMGPVGVLPPFVSMTSGLSGDEARRVARRATITALCVLLVFALGGQLVFRFFNISVNSLRVVGGIILLLVGYEMLQARPSRTKH--DEPAPEGYAEDIAITPLGIPVIAGPGAITTVIILMSEAHDLARKAVLLVVLLGLHVLTYAMLVSAKPLLAFLGPSGNKVLVRIMGLIVMVIAVEFFFAGLKPIVRDML-
20 UniRef50_A0NQU3 Putative uncharacterized pr... 163 3e-39 1 35.1% 8:212 2:211 -------LDYYINAFATLFVTIDPVGLAPMFLAITAGMSKHDRRKVAVRATITAAGILLVFYASGQTVLNVLGISVSAFRVAGGILLFLIAIEMIFGKRQARKTETAEKAMESEAheLAIFPLAIPLISGPAAISAIILLSSQAPDTLAYAGLGGVIAIILLSCMGAFLLADKIERLLGETAQLVITRLLGVLLAALSVQFVADGILAFIRT---
21 UniRef50_Q0C4W2 Membrane protein, MarC fami... 161 2e-38 1 30.5% 8:210 6:213 -------ISLFTAAFVTFFVLIDAPGVAPIFATLTAKGSPAYRRKMAYKSVFVATIIMLLFAFGGAWLLDAMHISIDAFRAAGGVLLFLIALDMVFEKRTERREQreEHRNDPEPEDVSVFPMGIPMIAGPGSIATAMFYMTEAESIAHQGVVLAAIGANLLITLIIFLLATPIVRLMGASVAGALTRILGVILAALSAQLILDGIRGAF-----
22 UniRef50_B9JF99 Multiple antibiotic resista... 161 2e-38 1 32.9% 5:211 1:208 ----MASADTLINAFTTLLVTVDPPGLAPLFIGLTAGMNRAERKQVALRGSLIAFFILAAFALFGASVLGILGISIGAFRIAGGLLLFWIAFEMVFEKRQDRKEKTTEVAITKDhhNIAVFPLALPLIAGPGAISATILLAGSLQTTFDRAQLIGVIAVNLGLVFAALAISDRLDRMLGATGRAILTRLLGVILAALAAQFVVDGVRSALT----
23 UniRef50_Q1GI30 Multiple antibiotic resista... 160 3e-38 1 29.3% 5:209 1:203 ----MIDTAFLITSFVTLFVIIDPIGLMPVFLALTQGMTSKQRRAIAIRASITGIGILAVFALFGESVLGFIGISMPAFRVAGGILLFLTALDMLFERRTARRQHQGDEIAPED--DPSVFPMAIPLIAGPGSIATVILLTGQHPGIEGFASVMAIVVAVIALMLGMFSISGALERLLGPVGINVATRLLGMLLAALSVQFVLDGLSAF------
24 UniRef50_B5EBI8 Multiple antibiotic resista... 159 4e-38 1 24.2% 3:213 4:214 --SAATHMEQLIVFVVQLFVIVDPLAAVPIFLAITVSHTKQERRSIARRGCSIGLLAIVFFLVAGPSLLRYFAINTSAVQISGGLLLFVIALELLYGNPTGTQTSSKEERLAEKKEDVSVTPLAIPLLAGPGAIVTCLVFSSQASDALSVLILIGGAVIVFSAAYLLLHWADELARIFGELGMKVAVRIIGLILAFIAVQYVINGITALWPAV--
25 UniRef50_B5JMP6 Putative uncharacterized pr... 159 4e-38 1 25.5% 6:209 3:206 -----SSLEFLLLSTVSIFTIVNPFSAVPAFLAITPGESVVERRRSARLACLIAVCLLILTAVLGEFIFSLLGITLPALQIAGGVLLFSIGFEMVRAPDAPKRLNETESDLAKEKEDISVTPLAVPLLCGPGSVSTVIILQGQTTSMMESSMLLVSIVVVFVACYLILSASAKGGEWLNPILMRILRRVMGLLFAVIAVQFVVNGVGDL------
26 UniRef50_Q59071 UPF0056 membrane protein MJ... 159 4e-38 1 32.7% 6:210 1:204 -----MDLQYFILAFSSIFSILNPFGAVPVFITLTESYPKKERDLVAKKTVIYALAILLAFALFGEWILKFFGISLDAFKIAGGILLLLISLDMVRGQ-QEAKIHRKEIEAAYEIDEIALMPLATPLLAGPGSITACMVAMAEASDIGDKFLVILAILLSLGITYLTLLSAESVLDRIGRLGIRILTRMMGLILTAIAVQMIVNGIRGAL-----
27 UniRef50_D1JFE0 Membrane protein, MarC fami... 159 5e-38 1 32.8% 6:209 1:203 -----MDYAYAVSVFIAIFAIVNPLGNIAFFTTLTQDYSKAEKKKVATKAIIAATATLIIFALVGRYIFVLFNITIPAFRIAGGLLLLMIAFSMLYGTTPGTKSTEKEKQESVEKEMVGVIPLGIPMLAGPGAISTVMLYIS-HGNIWDALIVFISVFATMAVTYIFLANADRIFNRVGRVGSLAISRIMGLILATVAIQFLINGTHEI------
28 UniRef50_B9NN29 Putative uncharacterized pr... 159 5e-38 1 28.8% 6:213 1:209 -----MESTLAVGFFGALFAIMNPVTNLPVFLSVTQDLSVADQRKVAIKTATYCLILGTAFAAVGSQALSLFGISVNDLRVAGGLVVLMIGFNMLSGNESTSHHGTDGEKESYPAAdvAFYPLAFPILVGPGTITTLILYAHHVKTTVDIFVYAGVFLAILALLLITFWNAAWLAKRLSANARVIMSRFMGMILAAIAISMIADGLKVLLPGL--
29 UniRef50_B5ZPR0 Multiple antibiotic resista... 159 6e-38 1 34.0% 5:210 1:207 ----MASADQLINAFTTLIVTIDPPGLAPIFLGLTTGMSRAQRTQVALRGSTIAFIILAVFALFGASVLGVLGISIGAFRIAGGLLLFWIAFEMVFERRQERKEKATEAAVTKDheNIAVFPLALPLIAGPGAISATILLAGTLPTSVEKAQFIAVIAANLLLTFLMLLIADRLDRFLGVTGRAILTRLLGVILAALAVQFVVDGAKAAL-----
30 UniRef50_D1JHZ5 Conserved hypothetical memb... 159 7e-38 1 26.8% 2:214 1:214 -MNTTTLVGFLCTCLGGYFAIMNPIANTPVFISLTQGDDAATKKAVARNSILFAFVLIAFLSFAGNFIFKLFGITQPALQITGGIIIFMIGYHMLQGSGSKAHTPSDDDIESSRKanVAISPLGIPILAGPGTIAVAMGYAAGFE-LIHVILSLLAFGVICGITYLCFRGSEEIVEHLGQNGLNVITRLMGLCLAAIGTGMVLSGLGADIHTFI-
31 UniRef50_A9A830 Multiple antibiotic resista... 158 9e-38 1 30.7% 6:210 1:212 -----MDVQFIILAFTSLFSILNPFGVIPTYLVLTSQYSKVEKIKIIRKSMLAAFTILMMFALLGNQIIGFFGISIPAIKITGGVLLFLIALDMIQGNTSKVEKSPkhSEEIEEMNEIAIVPLTVPLLTGPGSISAVIAMMAQTNDFDGKISVIIAISLCIIISYFVLKFSKDLERILGKIGFKVLTKMMGLVLTAISIQMALDGILMVF-----
32 UniRef50_D2RH21 Multiple antibiotic resista... 158 9e-38 1 29.3% 2:206 1:204 -MTCVDYISYFVTAFTTIFVIVDPPGNIPFFIALTERFSEKERDRVSKKSTLIACALLIIIALSGDILLKFFHISIESLKVAGGILLFVIAIDILLGGARKEFYAKRGLKH-IDVDSLAVFPIALPLYTGPGAITATIVLSAEASDIPSKILLIASIALVYIIVRLTHVYSEVVIKVLGKSGSDIVARVMAIFLAAIGVEYVFSGL---------
33 UniRef50_A6KWY6 MarC family integral membra... 158 1e-37 1 30.0% 8:214 5:209 -------LPFALLCFTSFFTLTNPLGTMPVFLTMTKGMDDEERRHIVKRATIISFITLLAFTFSGQFLFKFFGISTNGFRIAAGFIILKIGYDMLQARFTNTKLKDEEIKTYAN--DISITPLSIPMLCGPGAIANGIMLMDDANTWTMKGILIGIIGLIYFITYLILRASTRLVSILGETGNNVMMRLMGLILMVIAVECFVSGFRPILIDII-
34 UniRef50_A7JXE2 Multiple antibiotic resista... 158 1e-37 1 28.4% 8:215 5:213 -------IVHTVTVFMGFFAIMNPIANIPIFLSLTADEDKETVRSMALRSVFIAFVIIAIFSIAGKLIFDLFGITLYALRITGGILVFLIGFNMLQGDSTHQKTKEKAYSPAQqaLSIAVSPLAMPILAGPGTIATAMNF-ATAGGFDQTIITIVSFAVLCVITYILFLFGDKLVKAVGPSALNVVTKMMGLILAVIGTQMFIDGAGEAYKTVFS
35 UniRef50_Q11TX7 Multiple antibiotic resista... 158 1e-37 1 32.2% 8:212 1:204 -------MDLIFATVAALLPIINPFSTAPMFLSLTQGDTKSYRNAQATQGVIYMLAILLVSLVGGSFIMNFFGLSMPGMRIAGGILVAGVGMKMLKP-NDEIETTEAETKEAENKKDISFTPLAMPSLSGPGSISVVIGMSSLAKNISDYCYIALGIIFVACVVLLVLRSSVGLVKVLGVNGLHAMTKIMGFLILCVGIQFIIHGTMDILTG---
36 UniRef50_D0KYA2 Multiple antibiotic resista... 157 2e-37 1 24.4% 8:208 5:209 -------MHHALTAFMAFLAMMNPVANAVIFLGLTADMGLATTRHVAWRAVRTAFFIVLTFALFGPLVFSLFGITLPALRVAGGVLIALVGFRMLHGENSRVSHPKQIPSEssSQNDIAITPLAIPVLAGPGTIATAMSYSPS-GHWMQTGATILMFTLICALTFYAFVFSERILARIGRGGVAVITRLMGLILAVIGVQMLLDGLHQ-------
37 UniRef50_B2IEA6 Multiple antibiotic resista... 157 2e-37 1 34.8% 8:211 2:208 -------FPYLLQTFTTLFVVVDPLAMAPLFIAVTAGLTPVERRIVGRRACLSALFILLGFALLGETLLTVTGISLQAFRIAGGILLFWIAFEMVFHKRSDRKSAEVARTERPDETEiaVFPIAMPLIAGPGAIAAVIVATTHAPNTTAFFGVIVLIIAIMAMTFVVLQIADRIDAFMGPTGRAVISRLLGVLLSALAVQIAIDGVHGLIP----
38 UniRef50_C8WCE4 Multiple antibiotic resista... 157 2e-37 1 30.9% 8:211 2:207 -------ISLFISTCISLFVVIDVPGCAPIFASLTKNATSTEQRTMAIRAVLVSSGILVFFGFLGESFLRAVGIGLAAFRIAGGILVLLTAIEMVFEKRTQKREDrqVKKIPEEAEDISVFPMAIPMIAGPGSIATIMLLISKTENWEQRITVFGALGAIQIMMVISLILAGPIMRVLGRRAEAMITRVLGLILAALAIQFILDGLKEFFH----
39 UniRef50_A5WGW0 Multiple antibiotic resista... 157 3e-37 1 35.0% 9:214 3:213 --------TEIVKIILAFVVLINPFSALTLFLDSTRGYSMTDKRRFARISSLTVFITIAFFTVAGETLLKVLGISVGSFQIAGGVLVFLIAINMMNGEGNPVKPNQENVEVDDSFESiaVVPLAIPMMVGPGGISTVIIYSAQVTGWQQKLAIIIAGLLISIFCYLALMAAGQLSRFLGDTGLNIISRIMGMLLAAVAIEILVNGIKTVFPGLI-
40 UniRef50_B1ZWU7 Multiple antibiotic resista... 156 4e-37 1 28.3% 8:212 8:211 -------WELILGTVIALLPLINPLASAPTFLAITDGDTPERRNQQLRMACLYTVGILVSFLIGGTFIMGFFGLSIPGLRIAGGLLVAGIGSHMLMSPPKPATDDPVH-AAARAKRDISFSPLAMPMMSGPGSIAATISFTSLARGWIDYVAIILGIIIVTVITYVTLRISDRVVRVVGFNSMNALSQVMGFLILCIGIQFVVNGVTEIVTD---
41 UniRef50_Q7NGH4 Gll3195 protein n=1 Tax=Glo... 156 4e-37 1 26.5% 8:211 9:208 -------LGSAAGTFLALLPVTDPLGAVPIFYSLTSSGSDSYRRRQARLTTIHVLWLLAGFLLVGKVVLEFFGISFAVLRIAGGLLIAQTGWEMVNSH----RHEGDTALAANTSGDIAFAPMAMPLVSGPGAIGVVIGLSSKASGWPDYFGSLVGIALVAGVLYLCLMLGEPLLKRLGRAGTRALNQILGFLILAIALQFMVDGLRELLR----
42 UniRef50_D1BXK0 Multiple antibiotic resista... 156 4e-37 1 28.1% 2:211 1:209 -MNGILDVALFIEVFVTLFVIMDPPGSVPVFLALTSRMTPKQRNRAARQAILVAFGVIVVFAAFGQQLLQYMGITLPALQASGGLLLLFVAMELLTGK------MEEPEPAKGGAVNVALVPLGTPLLAGPGAIVATMVFvaDEPVLAHWAAIVLAVIAVHLCVYLAMRFANTIQRILKDSGVTLVTRIAGLLLAAIAVQMIATAVTEFVR----
43 UniRef50_B6R883 Putative uncharacterized pr... 156 4e-37 1 32.2% 5:215 20:229 ----LMTETALITYVAALFSMMNPIGNTGVFAGMTADRDAATARRIAWTCAGAIALTLLTVTWTGGILLKFFGITVHELRAAGGVIVLLIALSMLRSDNSH-RQTPQEAASAAEQNHIAVVPLAIPIVAGPGAIATAIVAAERHSGIWAKIDLSIAAVGLALFTGFLFSVSKPIANKLGESGMGVVTRLMGMVLAAIAMGMLADGVKGMIPALAS
44 UniRef50_O28169 UPF0056 membrane protein AF... 156 5e-37 1 29.0% 2:208 1:206 -MDIAGYLSFFFASFTTLFIIIDPPGNLPIFIALTERFSDEYREKISKRATIIAFLILFITMVTGGKILDYFGVSISSLKIAGGILLFISSVDILLGGTRREAYKRR-AEESIDVDSIAVFPLALPLYTGPGAITAGIVLYSQAGDVVMKLLVVLSAALVYSIVRLSHIYSAPIIRLLGRSGADIAARILAIFLAAIAVEFVFDGLAE-------
45 UniRef50_Q2FNQ4 Multiple antibiotic resista... 156 6e-37 1 27.5% 8:214 6:215 -------ISFSLFALSSILIVVNPLGALLVYNSITEFMDSKDKRKVAAYGCRIAGAVLIFFTLFGSSLLSLFGITISAFTVAGGVLLFGIGMEMVYARTSRAKVTATEKYESIDAEDISSMPLAFPMISGPGTITTVIVLSQDTPIFseLGIILGSVIVTILITYIVLISSEQITKRIGQREYRVVNRLMGIMLMAIAVQFIINGISQAFPMLT-
46 UniRef50_Q8TW39 Integral membrane protein o... 156 6e-37 1 30.7% 1:212 1:202 MGLEALDPYGVLKGVIELFVVVDPIGNVPALLAVTSELRPRDRVRVVHRAVAFAAVLILGFAVAGKATLDYLGISVEALMIAGGILLLRAAFGMVEGDPTGFRI------EPGSHIDVAYVPLGTPLLAGPGAIVTVIVMLHRHGRLE----TILACLIVMLLTLVTFRAAERLARFLGRSGIRVLTRVMGVLLAAIGVQMVLDGVSAFVRG---
47 UniRef50_C1D7D3 Probable multiple antibioti... 156 6e-37 1 25.2% 11:212 11:222 ----------FLFALAALLPIINPPGLIPIFLSLTSRNTREQRQFLARRIAIYGFVLLAGSMFIGSYLLSFFGVSLPVVQLGGGLLLTFTAWRMLNDTPAEHSTHAPEPEHIDQakQRAFYPLGFPLTVGPGSVSVSITIGATFFHSNHnvASLLAVAVVCYLIYFCYLHAETMLHHLGPTGAVVFLRLSAFILVCLGMQIMWNGISELISG---
48 UniRef50_B5I9R7 Multiple antibiotic resista... 156 7e-37 1 27.8% 6:210 1:202 -----MDVNTFLHIFIPLFAVIDPFAALPLYMSLTTGLSETQKRKIVKEASLTAIVLLIFFAFLGIYILDFMGISIEALMIAGGLLMLLVSLEMVKEG-DKPRSTKKKVALHEETGDIGIVPLGTPMLAGPGAISLVIILMSKYPTEWDSIVISI--VGIIILTALIFLGSNLISKIMGEKGSRAFTRVMGLLVAAFAVQYILDGVAQYF-----
49 UniRef50_B0C1W1 Multiple antibiotic resista... 155 9e-37 1 38.8% 5:213 1:215 ----MFDLPEYLKLVAGLASIVNPVGVIPIFLSLTEGQGSSQRRLIAFQSSIALSIVLLVALVAGEAILSFFSISLPSFRVAGGLLILLTALSMLRAETIESRQLTenEPPTLPDAPVAVVPIAIPLLGGPGAISTVIVYAHTQESIEHTILVGLAILSVSVIALVGLLIAPLMDTVMGKTGMNVISRVMGLIITAISIEFIADGVKELLPGL--
50 UniRef50_Q1IU42 Multiple antibiotic resista... 155 1e-36 1 31.9% 3:209 5:210 --FEAHIVQFTLVALSSVFFLVDPFAIIPTFLVMTARHDPITRRRMAARACWTAFIVLTAFAFAGTAIFKIFGITLPAFEIAGGLILLLIGLDMMQAERPTQEGSP-ETAEGSVKDDVSITPLGIPMLAGPGAISTVMVLNGTARDWSTTIPVFAAIALTCFASYWILRGAERVSQKMGQTGIRVLMRIMGLLLMAIAIQFMINGLTNL------
51 UniRef50_A7HDJ2 Multiple antibiotic resista... 155 1e-36 1 32.7% 8:212 18:224 -------LSLGFVSFSAIFFVVDPFSAVPFFLAMTRRHSAEERRVIALRASIAAGVVLAGFALAGAWVFKLLGISLGAFKIAGGVVLLLLALDMIRTQPSRTRITEGEVEAGADKEDIAIVPLAMPLLAGPGGIATAVVLMARagPWWHALPVLVAIALTAAASYAILAGATRTEKVLGRTGLAILERAAGLLLVAIGIQFMLDGLSESFVG---
52 UniRef50_Q8DGX4 Tlr2188 protein n=1 Tax=The... 154 2e-36 1 31.7% 8:215 5:209 -------LTFLLGTIAALFPITDPIAAIPVFYALTAKQSRRQRLKQARQVAINVAAVLTVFFFMGKLILAFFGISLPVVRIAGGLIVGHTAWQMV---TSQDRLTQQEHIEAADKVDISLTPMAIPLISGPGAIAMTISLSTRCHTWLEYLGAWLGILLLSAMVYLFLILGEPLSRAWGITDRGALTRLLGFLILAIAVQFIADGSLALLQTLLS
53 UniRef50_A5FN26 Multiple antibiotic resista... 154 2e-36 1 35.1% 8:212 23:228 -------MDLFIYLFAALFSVLNPIGTVPIFVGLTQHDSQKERSRISLWTAINVGIILLVSYFIGQYVLTFFGISIDALRIAGGIVIVNSGFSLLSGKFNKKRgnKKIENEVQQRNDIALTPLAIPMLAGPGSISLLIAFYQEHHQMEEILFSCLAILAIAVVIFVILKSAHYLARILGASGIVAISRIVGFIVISIGIQYIVSSIVNIIKG---
54 UniRef50_B2S4M5 Hypothetical integral membr... 154 2e-36 1 22.6% 1:212 76:277 LTPRMSTWTHIWSTAFTLLFIIDPIGNIPVVLSVLRTVPAERHTRIIFRELLLGLVLMLSFLFCGKVFLSLFQLETGVMKMAGSVILFLVGIKMVFPD--------QHALPSTTEEEPFIVPIATPMIAGPSAFTTLVIMGETKGT--SRLATCAALLVAWTLACLIMISAPCLYRLLKEKGITALERITGILLLILSIQMCVEGARGIIAT---
55 UniRef50_Q11II0 Multiple antibiotic resista... 154 2e-36 1 29.3% 5:212 8:216 ----MPPYDAILNAFTTLLVTVDPPGLAPLFLALTAGMNRQERHQVAIRACLISLGVLVLFALAGSSILSVLGITIPAFRVAGGMLLFVIAFEMIFERRQQRHKRSAERAITRdiHNIAAFPLAIPLTAGPGAISATLLLSGTASAPGARLVMVAILLVVILITYLVFVLAERIDRFLGETGRSILTRLLGLLLSALAVQFVADGARELIQN---
56 UniRef50_Q0A888 Multiple antibiotic resista... 154 3e-36 1 27.5% 8:214 5:213 -------LEYLIITFVAVFVIVNPLTTSFVFMALLPTASARRRRTIARRATVIATALFFLFATLGGLIFQIFGITLAAFRIAGGLILFGVAMAMIRQTLPSEAETAEQARNDEGrdDISVIPLAIPFISGPGAIATVMILTSEAPTLYHLALVYLAVLSCTVTCYFAMIYSRHIVRFLGDTGKEILTKIFGLILAVLAIQFVINGVSDAVTGYM-
57 UniRef50_Q12Z49 UPF056-domain protein n=2 T... 154 3e-36 1 25.2% 5:214 1:210 ----MDHVSYFINSFITLFVIVSPITGVITFITLTNGLSLREKNVIAKKSVTLAFIISMFFIFTGTIILDVLGISLDSLKVAGGLLLLTVAFDMMHAKISRQSITDKEINASYERDDIWIFPIAMPILAGPATITTAIILTETAEVVQQKMLLILAAVITYSVAMVTFLFSRRIHKKMGYNGMLVLTRLFGLFLGAISVDMIASGVWGLYMSMT-
58 UniRef50_B2KEY3 Multiple antibiotic resista... 153 3e-36 1 27.6% 6:215 1:218 -----MDFSFLIGAFVGTLSILNPIGNVPIFLEHVQTDSPKMQRAIALLLGLSIFALLIFFFFIGRSALNLFSITIPAFRIAGGILILLVGIRMMQGKSKFSNEGIQAAPAAQqrLSSIIVPVAMPLFVGPGTITTVILFSDNTKTLLNTVGMVLVLAICSAIVTICLLSSRYIYKILGNNGMQIVVRFMGMILCAMAVQFMIDGFAQLLPGVLN
59 UniRef50_Q7NUG9 Probable multiple antibioti... 152 5e-36 1 25.8% 1:209 1:220 MQLLSTFITKFLFVMAALLPIMNPPGLVPIFISMTARNTPQQRRYLARRIAIYCALLLVGSMFVGGYVLSFFGVSLPVVQMSGGLLITFAAWRMLNDTPAESSQPSAEQARVDSQAElaFYPLTFPLTVGPGSVSVAITIGATLTgvISPIAGLSAVLVGSTLVYLCYANADKLLRYLGQTGSVVFLRLSAFILLCLGVQIMWDGFGEL------
60 UniRef50_A0KDA2 Multiple antibiotic resista... 152 1e-35 1 35.1% 6:210 27:232 -----FDLTFSIKVFAALFAIMNPIANIPVFLSLTEGAADGVRRKVALTAAIGVTVGCIVSAVAGGAILHVFGLTIDDFRLAGGLLVLLIALSMLHGAPSRQHagADESADPAAADSVAIYPLTIPLLVGPGTIATMIVLGHGAVATGQEFAFALGLAAFLVLLAVSLLSAPLIGHYLSPRVTAVTQRLMGMILAAIAMQMIVASLKAAF-----
61 UniRef50_B6JA04 Putative membrane protein n... 151 2e-35 1 27.0% 1:215 1:220 MNNIAEIVNAFLLVYAALFPVINPVGGAPIFLRLTNRTPKARLPSLARGVAINSFVLLLCSLFIGSHVLVFFGITLPVLRIAGGLVVAALGWRLLHQGDD---LEGRDQPAPREKEVDAFYPLTMPLTVGPGSISVAITLGSQRPsaALGGGAATGLAAIAATIYVCYRFAGNIVTVLGERGTNVMMRLSAFLLFCIGIQIIWGGLRTLLPQLPS
62 UniRef50_A8HXT9 Multiple antibiotic resista... 151 2e-35 1 27.7% 8:213 5:223 -------INIFVAVFAALFPIVNPLGGAPIFYEMTRACAPQVRASLAMKVAIYGFILLVVSLVAGSRILTFFGISLPVLRVAGGLVVTFVGWNILHQGDASAEKAPDATATRdrVEQQAFYPLTMPLTMGPGSIATAIALGSqgHMIIEAMGALSGIAAVSASVYFAYRYASDIERFLGPNGTNVLVRLFAFILLCIGMQIMWLGIRDLVASL--
63 UniRef50_Q6L1H0 Multiple antibiotic resista... 151 2e-35 1 32.4% 5:211 1:208 ----MNYAYLFISSLVTLFAIMNPIGAVPILIALTDGYTKDERNNVILKSVFTAAGMMLGFMLIGVYIFQVLRISIYDFEIAGGMLLFKVAFDMLQGRTSPTKITSTEKEESVEREAIGVAPLGTPLLAGPGTITTAIifNGNGNAIMTRFVVIMSVIILIILTYIILKFSIPIFARLGKTGSIVITRIMGLLLASIGVQLVASGIINVFH----
64 UniRef50_Q03GN0 Multiple antibiotic transpo... 151 2e-35 1 24.6% 5:211 1:206 ----MNLVQAFLLSFTAFFAIMNPFANLPMFVSLTADNNRKEVDAIARLAFIVATVIVALFALLGNYIFSIFGINLSALRIMGGIILGLIGYHMIQGNVSPIQHDPKQSVKdsNNTDVAISPLAMPVLAGPGTIATTMNLSSSTNP----FIVISAFVVLSVITYFIFIYGEQIMAKLGNNIMNVITKLMGLILATIGVRMLIMGVQVAFH----
65 UniRef50_Q1H467 Multiple antibiotic resista... 150 2e-35 1 27.8% 2:210 1:213 -MSILEALKYISIVVIGLLPIMNPLTTIPLYMALTQRMTPETRKLQARKACIYAFFILTTFLLLGNGIIALFGISMAGIRVAGGLIILILALRMIFSGLDSSSSVDSEPEEIKSAndYSFSPLAMPSLAGPGSIAVVMSFGSQIPEGSHLiiVIAGIAITIGIAYLALSSATHIEKMLGEHGMQAVTKIMGFLLTCVAVQFLASGIRDFY-----
66 UniRef50_Q3SRM8 Multiple antibiotic resista... 150 3e-35 1 30.2% 6:210 1:206 -----MLPDYALTTFATLMVVVDPIGLAPVFLSITQGLPKAARRGIGWRASAIAAAILVATALGGTWLLARLGIGLPAFRISGGLLLFVVAFEMVLGVRPAREAQQATQAAEEHARNIAAFPLAIPMIAGPGAITATLLLAGRAAdpVQLIALIAIIIAVAAICGVTFALAGRVAGALGHTGNVVLSRLLGVVLAALAVQFVIDGIREAF-----
67 UniRef50_Q464W8 Multiple antibiotic resista... 150 4e-35 1 34.6% 7:211 5:209 ------NIGFLIHVFTIIFVVVNPISGVVTFISLTSKMRDEEKNEIAKKSVILACVIALFFAIAGDIILNLFSISVDSLRIAGGILLFSIAFDMMHAKISKGRITEEEISHSQEREDIWIFPISLPLLTGPGTISTVIVLMGGTGAIVQKIIILVSITLAFIICYYIFQFSRMIHKLIGYNGMLVFTRLMGLLLAALAVDLIVKGILNIYQ----
68 UniRef50_C1DAG1 Probable multiple antibioti... 149 6e-35 1 26.1% 5:215 6:224 ----IFFASKVLFVIAALFPILNPPGHAPLFLSLTVHNTPEERAILARKVGIYSFMLLLPSMFIGSYVLRIFDITLPFVQVGGGILVAIAAWEMLADKHGPSPEEQAEPHQLDQnsQRAFYPITFPITVGPGSITVAITVGASMQGKGLelASFVAVSLIAYSLYWSYRYADRLLRLLGPNGTMVFLRLSAFILMCLGVQIFWEGLTQLILQFTS
69 UniRef50_A8AGR9 UPF0056 inner membrane prot... 149 7e-35 1 28.7% 5:213 2:220 ----MDLFKAIGLGLVVLLPLANPLTTVALFLGLAGNMNSAERNRQSLMASVYVFAIMMVAYYAGQLVMNTFGISIPGLRIAGGLIVAFIGFRMLFPQqsPEAKSKSEELEDEPSANIAFVPLAMPSTAGPGTIAMIISSAStfPGWVILVAPPLIFLAVSVILWGSLRSSGAIMRLVGKGGIEAISRLMGFLLVCMGVQFIINGVLEIIKTY--
70 UniRef50_Q26F85 Multiple antibiotic resista... 147 2e-34 1 29.6% 8:213 5:206 -------LTFAFTVFTGFFAIMNPISNMPIFLTITEGADKETKQRINLKAIIVAFIIVSTFVLLGNYIFELFGITIPAFKITGGILIFFVGFEMLQSKKSNIKRLKTVNYD----ENIAISPLAIPILAGPGTIVTATNFVANTSSYADIAVVLLVFALMCLLNYIAFSLSDVIAKKIGDNVISVIGKLMGLIIAIIGTSMIISGLKLSFDVL--
71 UniRef50_Q0W501 Conserved integral membrane... 147 2e-34 1 27.9% 6:213 1:211 -----MNFELFVSAAISIFVMSDPFGNIPIFLSLTGGMNRPQRRRVITKASIAATVIIFIFAVVGQPAMNLLGISLNALSIAGGMLLLLIALDMLMSTGLHAKRTESTehEDEEADSIAITPMATPLIVGPGVMAATVVFMNRAAGLMDQALVLSAVLIAMLGSWIVMVNSDLLYAILHRDGTRVLTKVMGIILAAIATEMMISGLLNAFPAL--
72 UniRef50_A8FYJ7 Multiple antibiotic resista... 147 3e-34 1 30.0% 8:210 5:216 -------WLHLGTVFMGFFAIMNPIANVPIFLGLTSEEDEQTTKAIAFRALLLAFIIITVFALMGQFIFTLFGISLSAFRITGGFLVFLIGFHMLQGNNSSVHHPDSAQVEESKAksIAVSPLALPILAGPGTIATAMSFSA-VGGVAEMLITIGTFGALCVVTYLFFIFGGRLVNYLGSAALGAITRMMGLILAVIGTQMAIEGIKGAF-----
73 UniRef50_B8F4B7 Multiple antibiotic resista... 147 3e-34 1 28.8% 8:212 2:203 -------FDSLVVQFVVLWAVIDPIGSIPVYLAKTVGLSPEDRRKIARNAILIAAGILLFFLVLGQWLLDAMQIPLSAFQIAGGLVLLLFALTMIFGESKPD----QEIKMKSNLHELAVYPLAVPSIASPGAMMAVVLLTDNHrsFGDQVITTGIMLSVLLITYILFLVANRIQHFIGHAGAAIISRVMGLILSAVAINNILLGLKDFITQ---
74 UniRef50_B8GXJ6 MarC family integral membra... 146 4e-34 1 29.4% 5:215 1:220 ----MTEANLAVNFFVALFALIDPIGNVPLFAAATLGAAAAGRRMVAVYIGLFMAAFLIFFYFTGVGLLEFFGISMPAFRIAGGIILFILGLDmmFADAAEGIEDQSPRAYAKQRFERLIVPFAMPLLIGPGSISTVIIYAAEAKDFggMGIGVAVIAAVSLVTVLTFWASPLVSKVLGRIGMSIVVRVLGLILCALAVQFVLVGVADATRGLIK
75 UniRef50_C1D6U8 Multiple drug resistance pr... 146 4e-34 1 26.3% 1:213 1:214 MTLASLFSQYFLGAMLSFVVITNPLSKIPMFLSLTPGQTPVQKNRVAFTACAYAGAIMVVSLIGGNLVLSMFGISYGALRVAGGLVVAGVGYKMLYQAHDSTSHAHRESV------DVSFFPLAMPGISGPGTIAVVIGFSTEIAEITdiLITLGAIGGTMLVVWLSLKLSAKIAERIGPSALDVLTRLMGFLLICIGVQFVGSGIRTFYSTL--
76 UniRef50_B4WGQ9 Putative uncharacterized pr... 146 4e-34 1 26.9% 2:213 1:220 -MPIRDFADFILGSIAALFPVMDPIGSVPVFLVLTAGVPQSLRHSYARRIALNVIFLLISFLLVGGGILRFFGISLEVVRIAGGIVVFHAAWNTMNAESksELENQDAAQKAGEHKDISFMPMTIPLLAGPGSIAVVLGLAAEaeTAQNLLAVVIAIGLIGLIIYVALRSSSLLLKWLGAGGIQALSRLLGLFVMAIGVQLILSGLGDWIESL--
77 UniRef50_Q89AL9 UPF0056 membrane protein bb... 146 4e-34 1 56.1% 1:214 1:215 MNVEMFDFSIYISFFFSLFALVNPIGMIPIFTSMTNHQSIVERNKTNLIANFSVAIILSISLIFGSFILNLFGISINSFRISGGILVMIIAISMINGNFINNINNQKNGKLDKdaRNISIVPLAMPLIAGPGAISSTIVWSTHYSSVENIFGCMVTIMLFSCFCWTLFKVSPIIVDILGRTGINIMTRIMGLLLMSLGIEFILAGLKASCSNYF-
78 UniRef50_C0DXR4 Putative uncharacterized pr... 146 5e-34 1 29.6% 8:213 2:210 -------ITHILYLFTGLIVLNNPLIALGYFVDKTAGFTLKEQRKTARLVSISAFICMVVAGVIGTPLLKVLGIGIPAFQIAGGILVFVIAMSMMGGEDNPVKpkEHSSLPPEKQFAFAVVPMATPIIVGPGGFSIVIIYSSHVGTWQGALELLIACFMVGVTCYLILAGSARLSKILGNVGIKIINRVSGLLLAAIAVEIVLAGLRSLFPAL--
79 UniRef50_A6UWA4 Multiple antibiotic resista... 146 5e-34 1 32.3% 18:212 18:212 -----------------IFIIMNPIGLVPLFYIWTSESEKTEKIELLRKSAIAVMLTLLTFALFGGSIFKFFGITLDSFKVAGGILMLKIAWDMLHAQVSKTRHNLKDDEEPISLEDIAVVPMAIPLLAGPGTITTSIILMEHSITTYDTLIIMFSIILATLISVVILYLSDNIARILRVSGIKAIVRIMGLILAAISIEIISSGVFGLIKS---
80 UniRef50_Q11V88 Putative uncharacterized pr... 146 5e-34 1 28.4% 6:213 3:208 -----IDWSFALVVFTGLFAIINPIGNAPIFISFVDHLDKHQQKAIALKSVTVGFIILAIFVVFGYALFNVFNISIQAFRITGGLLVLKVGFDMINSKPKDAATLVKNSEATDTGF--AISPLATPILVGPGTLSTAVSFVGVGNKIENSIIIICSSAIILTITYFVFISSTTLIAKIGKEALNVVTKIMGLLIASIGIQMIITSIEELIHNY--
81 UniRef50_Q3DS24 Integral membrane protein o... 146 6e-34 1 25.1% 8:178 2:168 -------ISKFILAFMAFFAIMNPISNLPAFMALVADDDQKISRRIAAKGVLLAFVIIVIFVLSGHLLFNLFGITLAALKISGGILVGIIGYKMINGIHSPTNKNLEE--HKDDPMNVAVSPLAMPLLAGPGTIATAMGLSS--GGLSGKLITILAFAILCVIMYVILISANEITKFL-------------------------------------
82 UniRef50_B2JWZ3 Multiple antibiotic resista... 145 7e-34 1 24.4% 9:213 21:233 --------ETVLLVVAGLFPVINPPAAGFIVLSLVPHATEKERAFLARSISINSLVILLVSLSIGAYVLSFFGISLPALRVAGGLVIAFAGWNLLHEQADTDREPDQAPAHDVSResKAFYPLTLPITVGPGSIAVAVALGTGRPrwIHLAGVLVALALLWASIYLCVRFAANLEKLLGPVGTEIAMRLFAFVLFCIGVQILWLGVDDLLESV--
83 UniRef50_B8GMF3 Multiple antibiotic resista... 145 8e-34 1 31.0% 8:204 2:199 -------FETLLAAFVLLFIVVDPIGVAAIYAALVQGADRREQKRIARNGVLLATGILLTFMLLGNGLLAMLGISIPAFRVAGGVLLFILSLDMIFARQSGLRATtkEQREAVRSQDISVFPLAFPLIAGPGAMTTVLLMASSGHDALVLTGLMGVVLLVLALALIALWFAPVIVRGLGETGINVVNRMLGLILSALAVQFILD-----------
84 UniRef50_Q2RH58 Multiple antibiotic resista... 145 9e-34 1 28.9% 10:213 4:208 ---------FFLHAVVSILAILNPIGNLPIFLSLVEGEATADQIATARRATLAAFGFLTLFVLLGNNILLFFGITLAAFRVAGSIILFSIGYKILQGRNIHSRSLAPDIHEDiaRDDVAITPLATPILAGPGSITTVMLLVGSEWRLRTILLTVAAIAVVTLGTYLIFRYATLITRHLGPMEMNIISRVMGLLLAVIAVQMGASGLLELFPGL--
85 UniRef50_A1SUP4 Multiple antibiotic resista... 145 1e-33 1 25.0% 6:209 1:196 -----MDTTAYLHALTALFVIIDPIGAALIFNSLTGDCAKKHRTVMAVKAVLISGVTLILFGNYGEALFGHLGININSLRISGGLLLFYTAFNMV--------TKATGIMSASNSDDISVYPMSIPMISGPGTLTLSILLFSHTTELSGKLAVSSAIISILALTLVCMLVSKYLKKIIGKTGDEILKRFFGIILAALAIQFIYDGIKNI------
86 UniRef50_A5W9L0 Multiple antibiotic resista... 145 1e-33 1 26.6% 8:210 2:196 -------LHELFSVYLKMLVLYSPFFVLSCFISLTRGHSSKERKQLAWKVAFAALVASVMLYLFGRAIFGIFGITADAFRIGAGSVLFISALGMAQGKPAVQADNVQQ--------DVTIVPLTIPLTVGPGTIGALLVMGVSQPHWDEKLLAIVSIALASFTVGLVLYLSHGIERILGDQGLQIVSRLMGLFVCALAAQIIFTGIKGYL-----
87 UniRef50_Q0AE03 Multiple antibiotic resista... 144 1e-33 1 29.8% 8:212 5:206 -------MDQYIQAIVALLAIANPLSAVPVFLQAVDGLDRTQRRKSALLAAISVFTILFVAAVAGNWMLDIFGISISAFRCGGGLVILLMGLTMLQGRTSSV---QQESLTHNERRSKIFVPIAMPLVAGPGAITTVITIALAEPYWKNLSVALTAIVVLTMVLWVVLLLSQGVQGLLSPLGQKILLRFFGLILVAIGVQFILAGAYEFFTD---
88 UniRef50_C6BVR8 Multiple antibiotic resista... 144 2e-33 1 27.1% 8:210 2:197 -------LALFFQTYLKLFFVLTPFFAISAFLSLTQEMSPAERKKTAVKVTVAVIVSSVILYLYGRYIFDVFGITLDAFRIGAGAVLFLSALNMVNGGGKKFDAGKDD-------DDIAVVPLAIPIVVGPGTIGALLVMGSGVQGYKDMFLACCALVAAVLTVGILLFISSSLKRLLGKRGLNIMSRLTGLVVASIAAQIFFTGLRNFM-----
89 UniRef50_Q0W3L9 Putative multiple antibioti... 144 3e-33 1 31.5% 1:213 2:210 VFDSALSYTLFIHALVGVFVIVNPFGNIPIFISLTSKLTPAERRTAIIKSLLIATAILLVFALIGQAVFTLLNVTLPSLRIAGGLLLLAIAFDMLMGRSPASK-----IDESDEREAVAVTPMATPLLAGPGAMSTVMILMNEAAtdLQKLSIFLAILLAMGAAFLILINSELLYSVIKKDGSRVLTKIMGIVLATIAIEMMVNGLLKAFPVL--
90 UniRef50_A4SSK7 Multiple antibiotic resista... 143 3e-33 1 29.0% 6:212 1:207 -----MFFQVVFLALLALLPMVNPPTTATLLLGLSKGMSREHVRRQVNLAAIYLFFTLCITFFIGSSILDLFGISIPGLRLAGGLIIGFIGFRMLFPAPSQTNG-------VDINQSIAFVPLTMPSMCGPGTMALVISGAAqyNRLTIYGAMVTAFALMSLISWGVLKLADPVCKILGATGIDAMTRIMGFLLVCMGMQFCINGIKEVAQD---
91 UniRef50_A8GDQ2 Multiple antibiotic resista... 143 3e-33 1 29.0% 1:214 1:225 MTSILQLFQAIGLGLVLLLPLANPLTTVALLLGLSGNMTREERNQQSLMASVYVFFIMTVAFYAGQLVMNTFGISIPGLRIAGGLIVAFIGFRMLFPQQSADEAPEVESKSKetSANIAFVPLAMPSTAGPGTIAMIISSASsfAHWVLLVAPVAIFLSVALILWACLRSSGAIMRLVGQSGIEAISRLMGFLLVCMGVQFIINGILEIISTYT-
92 UniRef50_A5FZ91 Multiple antibiotic resista... 143 3e-33 1 25.5% 8:211 6:210 -------IADFLYAAVALFVIIDPVGTAIIFAALTTHDDAAKRRTIAKRASAISFLVLLVFGLAGEKLLRLLGIGIPALQIAGGALLFLSAKDMVTAKGELRASSEERSAASESTEDISVFPLAIPLIAGPGGMTTMVLLHAKAGGQPGAVLANALALAAMIAATLvmLGARRLARLMGATGASVVGRVLGILVAALAAQFIIEGTQAALH----
93 UniRef50_Q08WP7 Putative uncharacterized pr... 143 4e-33 1 34.7% 44:210 2:168 -------------------------------------------RRTALRACLVACGLLLFFAVFGGVIFQVFGVSLGAFRIAGGILLLITALDMLRARPTETRTSRTEEQESAAKEDVALVPLAMPLLAGPGAIASAMVLMAKGGTLLMTVPVLAAIVLTFVASYFILRASHLVQRALRQSGVAILERVMGLILAAIAVQFMADGAKDLL-----
94 UniRef50_B5JIG7 Putative uncharacterized pr... 143 4e-33 1 30.4% 5:208 1:204 ----MGLLEYTLLAFVTLFVIVEPISIAPIFLAMTAGNDRSARTRTAKIACVTMVTVLLLFAVVGMSLLEFFGISVAAFQTSGGILLLLIALDMLQAKESSRKITQEESDAGTAKEDIAITPLAVPLLAGPGAITTCIVLANQAEAWDQRMALYGVIIFICGLTFLILKLADKGAAWMNPLFMRVITRLAGLLLAALAVQFIFNGLRD-------
95 UniRef50_B4ETK1 Multiple antibiotic resista... 142 5e-33 1 29.0% 28:213 28:222 ---------------------------VALWLGLSGNMTKEQRNQQSFMACVYIFIIMTIAFYAGRVIMTTFGISIPGLRIAGGMIVAFIGFSMLFPHTPnpLSEEKNPHRNPQAPNIAFVPLAMPSTAGPGTIAMIISTAASIPswVLYVAPITTFFLISLIVWLSLRGSTGIMRYLGHSGIDAISRVMGFLLICMGVQFMINGVLEIIADL--
96 UniRef50_C7JEW2 Multiple antibiotic resista... 142 6e-33 1 23.4% 5:213 16:234 ----TSSISSFLLAFPALFSIVNPFGAALIFAQATAGRSQTEIMALARLVSFYSLCLIMASLWLGSMVLAFFGITVNALRVAGGLVVAVRAWDLLQSPETVEAQKEKQALqaPNWADAAFFPLAMPFTVGPGTIAVAIALgaDEPFWAYTIGTTLAGVCVVAIVWAAYSGADKLVSMLGVTGTRIVSRMAALVLLCIGVQILAAGVQGFATDM--
97 UniRef50_C1DWJ6 Putative membrane protein n... 142 8e-33 1 29.4% 5:215 1:211 ----MDVLYLILKYTISIFAIVDPFGAIPLIISVLKNFSDKEREFIIKKASIYGCFILIFFLFLGNFFVGILGVSIADFQIAGGIILLLISINIIFGQPLKEKISPEEIPLIKKLENIALIPVATPILAGPGAMVTAMTVASSQESLLNLLIVAISIVITFLISYFILKASKYIQKLLGEIFLDIVSRMMGIVIMALAVQFIVKGIKQNFFPILH
98 UniRef50_Q164H0 MarC family integral membra... 142 8e-33 1 31.0% 7:209 4:203 ------DTAFLITAFVTMFVVIDPIGLAPLFVALTHGMSDEARRRIALRATLIAVIILLAFATFGEALLTFIGISMPAFRVAGGVLLFLTALDMLFERRTKRRED---RSEEDDSDDPSVFPLAIPLIAGPGSIASVILLMGQRPGLEGAVMVLGATGLVMLIVLAFFLISGPVGRALGKTGITVVTRLLGMLLAALSVQFVLDGLAAF------
99 UniRef50_B4E5W5 MarC family integral membra... 142 1e-32 1 24.4% 9:213 3:200 --------YTFLSATVLLVLITDPLGNIPLFISAMRDVPRERRVKLILREVGIAFMILLFFMVVGDRFLRMMSLTDLSLRLGGGIVLFLIALRMIFPHPDGALG-----SDPRAGGEPFIVPLAIPALAGPSALATVMLLTSQAPG--KMFEWVGALTVTMIVCAITLVLAERIQAWLGERTVAAFERLMGLVLVAISVEMLLAGIRAFVHQL--
100 UniRef50_Q2SCP9 Multiple antibiotic transpo... 142 1e-32 1 43.1% 5:213 1:210 ----MLEFHEYTKILIGLMAIVNPVNAVPIFVAFTSNVSGAERKKIGKSVVIAVGLILLISMLLGEYLLSFFGITINSFRVAGGILILLMAISMLHAKVSATVHTEEETVEEEGHhsVAIVPLAMPLLAGPGAISTVILYAHRGTDAAHYALVGVAILILCLTLWLVFSMIPWFSSHLTKTRINIFTRIMGLILAAIAIEFIANGLKGLFPVL--
101 UniRef50_A8UZ22 Multiple antibiotic resista... 141 1e-32 1 28.8% 2:213 1:213 -MEVFDYLRTLLQFTIGLITILNPIAAAAIMVSltPPVSKRELVSISKKTTLTILTASLLSTFLGDLIFKLFDINIHSIKVIGGIILLLFSINMIKGKIFEASHTPEEHEEAKEKDDISIIPLGIPILFGPGTFTTLVIFKTSTHNWIDLFILITAIFISSVVVFLVFKNAVLLDKFLGITGVKITTRIMGLIVGAIASQFIVSGVKSLWDMY--
102 UniRef50_A5GJB9 Uncharacterized conserved m... 140 2e-32 1 27.5% 10:213 2:203 ---------SLLHTAVGIFTISNPIGNLPIYLSFTDGNRRKDR-AIARSSAVTFLVSLMLATWLGNDLLGFFGISRPAFQVAGGLIVVLIGLSMLRSEPSKVHHDPASIERDQDSAVKGIVPLGIPLLAGPGTLTVVIA-DPNAASMGGKLGISGVVLLLTVVVYVIFEAGEMLSSKISASALQVLTKIMGLLLTSIAVQMIFTGLRAGFPVL--
103 UniRef50_A3JXR0 Multiple antibiotic resista... 140 2e-32 1 29.4% 6:206 3:201 -----LDWSALLREFITLFVVVDPIGTLPVFYFATARVPQELHWKFAVRAVLVAWVVLIAFLVAGQWLLEGLGLRFGSFQIAGGIILFLFALTMIFG---ESKAEHEIEEAAREHFSGAVFPLAMPSIASPGAMLAIVVLtnHAHSVPDQLMTAGLLTIVLILTLLLLLLGAQLKRVLGSTGASVVSRVMGIILATVAVDAVLGGL---------
104 UniRef50_Q3SH12 Multiple antibiotic resista... 140 2e-32 1 38.8% 6:214 5:214 -----MDLLELLKAALALFAIVDPVGVIPIFLMATHGFTLTQSRAAARIAALTVLGVLTIFAFAGETLLTFFGIRLAAFSVAGGLLLLLLALSMVEAHVSPQRQTQDEAVEAEEKDSVGVVPLGVPLLAGPGAITHVIvaGALEGHTLQRGLLLLPVGLVALSVWLAFRAAPVIAKRLGKTGIHVVTRLMGLIIAAISIEMIARGLGELFPGLL-
105 UniRef50_C5BZ38 Multiple antibiotic resista... 140 2e-32 1 26.8% 2:210 1:203 -MSSIIDVTLFSTTFLTLFVIMDPPGTVPVFLALTSTMTAKQRARAALQAVYVAFGVIMAFTLFGQAILRFLHISVPALQASGGLLLLLV-------ALELLTGKAEEPQPSGRGVNVALVPLGTPLLAGPGAIVASMLAVQQggDVASWVAIIAAIVLVHVSLWIAMRFAGVIHRVLGEGGTTLVTRIAGLLLAAIAVQLIADAVRAFV-----
106 UniRef50_Q21G51 MCP methyltransferase, CheR... 140 2e-32 1 27.0% 8:211 1:202 -------MIDYLAVFITFFAVIDPIGTVPVFIAVTREYDQKTKRRIALLATIVAACVLLFFVVIGEIILKALSIPLSAFQISGGIVLFLFALNMIFGDSKPE---EEIKFLEDDHKDTAIFPLAVPSIASPGAMLAAVLLTENafSLFEQVQTVVMMLLVLVVVYILMLLSGFITRFIGTSGASVVSRVMGLILSAIATTNILTGINEYYQ----
107 UniRef50_B3EKF2 Multiple antibiotic resista... 140 4e-32 1 25.6% 8:210 5:206 -------LSHTLVMVGGYFAIMNPLANTAIFTAVTAGMDDRGIKKTALSAVVTALCIVLCFILLGRIIFDFFGITLPALRVAGGIMVFFIGFDMMHGRTSAAHAPAGGGASGTPGQNLGISPLGIPILAGPGTIAVSMSYSATGNGL-DIAVNALVFSVMCLITYVFFLLGEKVEQKLGREGLKVITQIMGLILSVIGVQIGIEGIFGAI-----
108 UniRef50_Q31LF6 Multiple antibiotic resista... 140 4e-32 1 30.0% 6:215 1:216 -----MNWPLVLNFAVALFAVTNPLGNLPIFISYVGKEKPSVQRLLALFLVLTVFISQLVFLLSGTAILRFFGISLAAFRIAGGIILLLIGINMIQGDRTKANQKLADirRAETVYQSFFIPLGIPIFVGPASISTAVLYGNLANNLATNLGLIGAVIAICIVSWLTLSVASWFERILGDLGLEITSRLLGLMLAAIGVQFILNGLGEATIGFIN
109 UniRef50_C5CP73 Multiple antibiotic resista... 139 4e-32 1 34.4% 5:213 1:213 ----MSTSMDLIKPLVTLVAIVNPLAIVPFFIHYTQGYSDAQRRHTVRMSAFSAFVVIAVSALIGLQLLAFFGISIASFQVGGGLLLLMSSLSMLNAKPAESKTNVEELRATEVKAsiAVVPLTIPLLTGPATISTVVIYADKTQHLWELGLLVGYGVVVALATALAFSLAQPIARVLGKTGINIMTRLMGLILAALAVEVMADGLGKLFPIL--
110 UniRef50_B8ELV6 Multiple antibiotic resista... 139 5e-32 1 25.9% 7:211 4:209 ------EWALFLSTFATLLAIINPFEALPIFLMLLEGKDLSEHRRVAARATLYATLLLFFFLIFGSLIMQLFGVPLSMVRIVGGIILVKIGFELFSPSPNGGSIIPD---ASSKTANFAFVPLALPIMCGPGAIATVLGMQSEieHIGRFAATSLAILCAMFVTYLCLAYAGKLVDKLGPMGIDATTRIVGFFVSAMGVGLVFNGVLQGLH----
111 UniRef50_C7RRV2 Multiple antibiotic resista... 139 6e-32 1 20.8% 7:213 4:210 ------TLTLFISLFTTLLAIINPLEAIPVYLGLMENRPESEQRQVARRACFYATLLSFFFLIFGTLLLRVFEVPLSMVRVVGGVILTRVGFELFAPPPSGGLI----PRSGGNDTDVAFVPLAMPIMFGPGAIATLISMAssAEELIYFLAASLAIIACLGTTYISLIYAKPILRKIGTQGIDAATRIVGFFVAAMGMGLIFNGAVEFLESY--
112 UniRef50_A4SWC9 Multiple antibiotic resista... 139 8e-32 1 26.0% 8:211 6:219 -------LASFVTVFAALFPVINPLGDGPIFLNMVQGCSEGVRNKLARSVSVNCFFMLLASMLIGPQLLLFFGISLPALKLAGGAVVIAMGWNLLNQKSASDKGANESTGITDETSdsAFFPLTMPLTVGPGSIATAIALVAAYqeLPAVIGTVAALFALSLTIYFIYRESSGIQRIFGVNGTNVLMRLFAFILLAIGVQIFLGGINGYLE----
113 UniRef50_C9YF10 UPF0056 membrane protein bb... 139 9e-32 1 23.4% 5:213 17:215 ----AMMNYTFASATILLILITDPVGNIPIFANALKHVAPERRPKVILREILIAFTLLLTFMFVGESFLRVMNLSELSLQIGGGVILFLIALRMVFP--------PAATAETEIKTEPLIVPLAIPAVAGPSALATVLLLVSQQPDR--RMEWIGALCVTMLVSAVVLVSAERIQRIIGDRLVVAAERLMGLVLVSVAIEMMLRGIKTFVHQV--
114 UniRef50_D0XZK3 Multiple antibiotic resista... 138 1e-31 1 28.1% 5:214 1:218 ----MSIQYLALNFIVALFALINPIGNLPVFAAMTAGAKPKARRRIAVYIGVFIIGLLGIFYLSGLALLQVFGISLSAFRIAGGAILFLLGLDMArdEADELASLADHPSYARRLFERILVPFAIPILIGPGAISTVVIYASETRSMgaMAAGMIGICAAAAAVVAVLWATPFISRLLGRVGMTVTVRVLGLILCAMAVQFMIMGAADATHGFI-
115 UniRef50_B5EQ08 Multiple antibiotic resista... 138 1e-31 1 27.9% 6:213 18:223 -----SNIEIFIQTLVTLLVLMDPIGIVPIFVSLTREQSTDQQKTTAKYISIVVALVLIISTLFGNDILRYFYIGIAEFNVSGGLLLLLMSIQML--TTDNISTTFGQGQASAYHGGRLVTPLGIPFLAGPGAIGTVIIYGQHAHTILSYGLILIDVLIASFAAYIAMHNAHHISRFFGEIGIEIITKVAGLILGAIAVRFICQGLIRLLPGL--
116 UniRef50_Q2SQZ5 Multiple antibiotic transpo... 138 1e-31 1 29.8% 11:215 3:198 ----------IVSALTLLIVVMDPLGNIPLFLSILERVDVKRRKKVLFRELLIALAILLVFLFCGQYLLKIFSLSKESVGIAGAIVLFIIALRMIFP-------AKREWLEDLPDGEPFIVPLAIPFVAGPSALATLILISTREP--ERMMDWSIVVLLAWSVTAVTLMSSTFLYKVLRKRGIIAIERLMGMLLIAVSVEMFLTGLQPILTKLTH
117 UniRef50_D1B0T6 Multiple antibiotic resista... 138 1e-31 1 25.1% 8:214 5:212 -------FNLLLQHTITMMAIVDPLGVSAIMLSLLPQSTTKEHikIARKATLTIIVAFFVVLISGNFLLNLFSIEIDSLKVMGGIILLFTAIKMVQGSMESKNQTEEEREEAIKNDEFSVIPLGVPITFGPGIFATIIILRGHSEGFISIAALIMAYLIVALSVYLAFKNSIYIRKYLGITGQKIVSRLMGLIVGAIAVQFIVGGVSVLVKHYM-
118 UniRef50_A9NB13 Membrane protein, MarC fami... 138 1e-31 1 26.9% 10:210 2:192 ---------TLYTIAITLILVMDPLGNIPVFLAILKQYDARTQVRIILRESIIAFFILALFVFFGRYILHGLHITTPALSIAGGVILFIIAIRMIFP--------PDQKPAKEDFEEPLIVPLAIPLTAGPSAMAMVLLFVTRDPH--HLWLIFLGVFIASLIFTLIMLWAPYLIKILGKRGLTAIERLMGMILTTIAVQMFLAGIAEYL-----
119 UniRef50_Q2FRJ2 Multiple antibiotic resista... 138 2e-31 1 29.2% 6:214 3:218 -----SDVGYLVGAIGTFFAILDPFGNLPFFIAYTNTLSAPVRRKTALVLSAFIFVAMAVFLFSGQMVLSFFHISLPAFQIAGGIILFGVALSMMSGTHtsDTGKEMLLEKNESILPTIIVPLGIPLYVGPGSIAAAILFGSNAPTETAFLGGLLVILLIVIFITILNLSSDYIGKVLGNQGIEILVRLMGLVLAAIAVQLTLDGITGAITTMI-
120 UniRef50_B8ICA0 Multiple antibiotic resista... 137 2e-31 1 26.1% 8:214 8:230 -------LQSFLLALPALFSIINPLGGALIFAEVTGRRTHEERVLLARRIGIYAAAVMLVSLWLGATLLSFFGISLAALRIAGGLVVAAQAWRLLAVPEEREArdREVGVESGGLDEIAFFPLTLPFTTGPGTISVIIALAASRprWGFLLGATLAVLVIAASVRIAYASADRVVKRIGHARARVLGRLSAFLLLCIGTQITLTGVSDVLEPLL-
121 UniRef50_Q0FG46 Multiple antibiotic transpo... 137 2e-31 1 32.7% 8:209 2:200 -------FELFVTAFVMLFLVIDPIGLLPIFISLTLGNN-KNRLKIGLRACSVALGILLLFGLLGENLLSFIGIGMPAFKISGGLLLFLTAVEMLF---SKRGQRREEQTEMDVHDDPSVFPLATPLIAGPGSMATMILLlsDVSGVTSTLVVLSAMISVVFLTFIFFSLGGPFERLLGKTGINVITRLMGMLLAALSVQFVVDGLNGL------
122 UniRef50_A2BM88 Predicted transporter prote... 137 2e-31 1 26.7% 7:212 8:204 ------NTETLVQSIVLLFIAIDPIGNAPLFYSLTARLDARLRVRIVKQSCIVATSILFVFALTGNTALSYFGLTLADFRIAGGIVLLIYGIAGILGWTEAEMIRHPEEVE-----SIAIVPLATPLLAGPAAIATVLYVRA----VHGLTYALASVTVNTAITFLMLYHSQKLMNLLGKNGAIALSKIMAMLLAAIAVAMIRTGIQDILAT---
123 UniRef50_C7R1Q1 Multiple antibiotic resista... 137 2e-31 1 28.0% 2:212 1:206 -MNDIIDIRLLIEVYVTLFVIMDPPGTVPIFLGLTGSMTAKQRAGAARTAIAVAAGVILAFAAFGQQLLTYMHISLPALQASGGLLLLLIAMQLLTGKMEEEADSPSNK-----NVNVALVPLGTPLLAGPGAIVASMLFVQRADASADWFALAVGFAAICLTLWVSMRFAGVIHRLLGESGTILVTRIAGLLLAAIAVQLIADAVIAFVRD---
124 UniRef50_C6XRN8 Multiple antibiotic resista... 137 2e-31 1 27.9% 6:209 1:201 -----MDWGSLYRDLITLFVVIDPIGTIPIFIAVTAGMAPENRPKVALIGVLIAAIVLYTFLILGQLVFEALGLALGSFQIAGGIILFLFALQMIFGPSKP----EEELNQAKSISQSAVFPLAMPSIASPGAIMTVIILTDNhhSVLEQTATAGLLLGVLVFTFVLLLLANPILKLIGTSGASVISRVMGMILSTVAVDAILNGFAVL------
125 UniRef50_C3X219 Predicted protein n=2 Tax=O... 137 3e-31 1 29.0% 6:215 1:207 -----MHWGFLIKKTLTLLALVDPLMAIPLFICATAGLDTGFKDKYSRQLGITVALSLLIGGLFGLHLLDFMGVSLASIQIGGGAIMFIVSLAMVIAKEETIKYTPRETEEAASG--PSIVPLGIPLLAGPAALSYVMA-TSQITQAEDLLSVILPPVVVGAATWLCFRFVGRGGRILTPSAIKVIERLAGFLLTAISVEMMATGFRHVFPGLSS
126 UniRef50_C6E1T4 Multiple antibiotic resista... 136 4e-31 1 29.1% 9:211 6:200 --------EFFFTVWIRFFFLLTPFFVLSTFLAMTPELSASERRATALRVTLAVLIACFVLYSFGNTLFSLFGITLDSFRIGAGSLLFLSAVHMVQGDDS--------APPSEKRGAISVVPLAIPVTVGPGTTGALLVMGAEVQHNWQVFVGLAALAAAVLCVGILLVCASFIEHIVGKKGITILSKLTGLFVAALAAQIVFTGVRNFLQ----
127 UniRef50_UPI0001746B52 hypothetical protein VspiD_... 136 5e-31 1 24.8% 6:211 1:197 -----MRPTDWISALVLLLIVLDPLGNVPVFSSLLRQVEPARRKRVILRECGIALVVLFLFLAFGGGFLKLVGLSQSSLGIAGSIILFMIALRMVFESTEKVFGGLPQG-------EPFIVPMAIPMLAGPSALATVILFTTREG--ISTLGAVGAISIAMGVTCIVLLLGERIIRLVGERGLAAMERLMGLLLTAIAVEMFLRGVKEFMK----
128 UniRef50_A5G1Y0 Multiple antibiotic resista... 136 6e-31 1 28.7% 6:214 1:217 -----MDLAFAARFLGAFFAIMNPFVTLPIFLSMTADRTVAEQRSIALQIGTYSTVMCLVIAVAGNAIIGFFGISIDAFRVAGGLVLLGIAFSMLNGHPITAHERGDHEKSADSagGIAFYPLTFPLVVGPGTIATLIIYAGQARGVPEYVAFGLITALLLAVLIVVLYFAASIGRLLSARMRVVMTRLMGMILAAIAVGMVTAGLKILLPGLT-
129 UniRef50_A1ANN4 Multiple antibiotic resista... 135 7e-31 1 29.1% 9:211 6:200 --------SFFFGIWIKFFFLLTPFFVLSTFLSMTQRYEARERRKLALRVTVAVLVACFTLYFFGNTLFSLFGITLDSFRIGAGALLFLSAVQLVYGDDKAPPGGEREV--------ISVVPLAIPITVGPGTTGALLVMGAEIQQSWEILVGCAALATAVLCIGLLLFCAASIEHLIGKRGIIILSKITGLFVAALAAQIVFTGIRNFMT----
130 UniRef50_D1JAD6 Conserved hypothetical memb... 135 8e-31 1 27.6% 1:214 1:217 MADYAQALTFSIGAIIAILVISNPISTSAIFIALTERMSRKQKQDTIKKSLTYSAGILILFALTGLLLFRIFGFTIGAFRIAGGVLLFTTAVGMLNPKTS-------QEEATDVPDNIALIPLSIPFTAGPGTIVTVVVLMSEVENIMHslGVFIGIATCLGVTYVMLAKSDLIDGALKEGGRRVVTTLMGLIVMAIAIQFFINGIKDILPDFM-
131 UniRef50_D1N302 Multiple antibiotic resista... 135 9e-31 1 27.4% 5:212 1:203 ----MMDVNMFIGMVVQFFFLLTPFFVLSLFVSLTSGMELPRQRKLAVRTTLAVMTIVLIIYLLGDRIFGYLGISLDAFRIGAGLVLLLSGIEVV-----RSSGTPSGTRQCDDDGDIAVVPLAIPYTVGPGTIGTLLTMGASADSARLRVTQIAGIVIAVLIMGLLLYFSAALERLLKKKGLNILSKLTGLFLAALASQLIFTGIRNIMFG---
132 UniRef50_B8D4C1 Multiple antibiotic resista... 135 1e-30 1 25.1% 5:215 1:202 ----MDYLIILLSYFTQLIAIMNPFSAIPTFMSLTEGLERRRRLEIVKKAYFAGLILVILFTLVGRYILEAFNISIASLRVGGGIILMTIALDMLGDEVRTKRMHP---------GDIAVVPIATPLIIGPGTITTILLLTSSLQETTGMVVVLIAGVIACSVTFLILALSDILTRLLSMSTVRAIGRFMALIISGVAVEMIVQGLYSYYVELFK
133 UniRef50_Q01Z86 Multiple antibiotic resista... 135 1e-30 1 24.6% 9:215 12:225 --------KTTLLIVGALFPIVNPIGNTPIFLSLTHGLSSQGRTVLARMIAINGLILILASIFIGTHILAFFGISLPVVQVGGGMVVIATGWTLLRQPNDDGssGARDECHEADYKRQAFYPLTLPLTVGPGSISVAITVGANRprWPLIGGMLLGSALIAVSIYLSYRFAERLAQTLGDSAMNVMIRLSSFILLCIGVQILWNGLSALLRTVVH
134 UniRef50_A4BBV6 Putative uncharacterized pr... 135 1e-30 1 32.2% 6:210 3:206 -----MNTTFFFNALTSYFVVIDPIGCALIFYSLTLGQSTRQKAKTILKSMAIALGIILSFAIAGERLLTALGISMDALRVAGGILLFNTAFRMIT-KVPEDQSLHHESPHDVRIGHITVYPLAIPLMAGPGTLTLTVLLMANGEQTVDQVMVIVAAVIVLLVTVLLSVLSGKLRKVLGQTGDEIIQRLLGVLLAALAIQFVANGVNGLF-----
135 UniRef50_C5BLR4 MarC family integral membra... 134 2e-30 1 29.6% 8:206 1:201 -------MEYFIVAFMTFFATIGPLDVAAVFAALTARYKPREARKMAVKGILISISILLLFALSGEWLLSQLGISLAALRAGGGILLLLIGIDMVFARTsgTSTTADEEEEAITREDISVFPLATPLIAGPGSMGASILLMANagHPWQQGAVLLALAAILLLTLVMLLAAAQIQRILGVTGMHVITRVFGVLLTALAVQFIFDGV---------
136 UniRef50_A9W5P7 Multiple antibiotic resista... 134 2e-30 1 25.1% 8:214 11:226 -------LTSFLLALSSLFSIVNPVGSALMFAQITSDRSQAERAELSRRIGFYAALVMLAALWAGAPILNFFGVSLAALRIAGGLFVAAFAWTMLTAPEAREARKhaEPEAGENLAEVAFFPLTLPFTTGPGTIAVAIALGANRPSEPGELaaSLAALAIAGVIRLAYGSADRVVTLIGSVRARVLGRLSAFLLLCVGTQITVSGVSDVLGPLI-
137 UniRef50_B5HXX6 Integral membrane protein n... 134 2e-30 1 29.8% 5:212 1:200 ----MFDVAVFGSLFLTLFVIMDPPGITPIFLALTAGRPGKVQKRMAFQAVCVAGGVIAVFGVLGHQILDYLHVSVPALMIAGGLLLLLIALDLLTGKTDEPKQTKD--------VNVALVPLGMPLLAGPGAIVSVILAVQKAHSVATQVSVWTAILAIHVVLWLVMRYSLLIIRVIKDGGVVLVTRLAGMMLSAIAVQQIINGITQVIQG---
138 UniRef50_C4XI48 MarC family integral membra... 134 2e-30 1 33.3% 10:213 4:205 ---------TFQHYLLGLFAVANNIPALPLFMNLCRGAQTPVQHRLCGVATASSLATMAISLFIGAAVLDFFGISIAAFRIAGGLLLVSSGLSML--KSSCDEADGLPPVSVSRMIPMAVVPIAIPLTTGAGTISTIVLFAESAHTMAGLLRIGGAICVMSVVNYLAFYYSPAIVRFLGRTGMDIFTKIFGLITLALGIQFIITGLTAAFPVL--
139 UniRef50_B0UBD2 Multiple antibiotic resista... 134 2e-30 1 25.6% 8:214 11:254 -------LQSFLLALPALFSIVNPLGAALIFAEVTGGRSHGERALLARRIGLYAAAVMLISLWMGAALLSFFGITLAALRIAGGLVVAAQAWRLLAAPEEREARKAAQAEPAKSrdEIAFFPLTLPFTTGPGTISVAIALGASRPESGalLGASLAALVIALSVHLAYASADRVVARIGPARARVLGRLSAFLLLCVGTQITLTGVVDVLAPLL-
140 UniRef50_Q89AB7 UPF0056 membrane protein bb... 133 4e-30 1 23.6% 8:210 1:197 -------MKEIISVTILLILIMDPLGNLPIFMSILKHLEPQRRKKILIREMMIALLIMLLFLFAGEKILIFLNLRAETVSVSGGIILFLIAIKMIFPTYESKKK----SGNIIKREEPFLVPLAIPLVAGPSLLATLMLLSHQYPK--KILYLIGSLLIAWMITVVILLLSDIFLRLFGSKGVNALERLMGLILIMLSTQMFLDGIKSWF-----
141 UniRef50_B1L4D5 Multiple antibiotic resista... 133 4e-30 1 23.7% 6:212 1:202 -----MCIEEVGISAIQIFAILNPISVIPIFLSLTEGRDEGEVRRIVGVVSVAIFIMMSIFSLAGELILKLMGISVRGLKIGGGAILMVLAVDMLQGMPRTKSVEEEE---------LAIVPLSTPLLVGPGTMTTILLLSNKYSGTYGylILTLASALVTVASYLILRNSGKLRKVLGVNGLRGLGRFMAIIVAATAADMISSGILDFIKS---
142 UniRef50_A3CST1 Multiple antibiotic resista... 133 5e-30 1 27.0% 1:215 4:208 ITEIAGFVGLTLVAVASITAVMNPASTTAVFTALTEGMTPDERRQVILTTVRISFIVLAFFALTGQLVFSIFNITVPAFQIAGGILLVTVATGML--------GSRGESYQAGDLENIAIVPLAFPLSCGPGTITAVILLTS--AGASSLIAVFLGIAVALVISYVGMLYGPRIFAFIGEGGLRVVPKLMAVIVLAIAIQFIISGIAEAMPQLLS
143 UniRef50_Q3JBV2 Multiple antibiotic resista... 133 5e-30 1 29.3% 6:213 9:258 -----FNWELLGNFFAALVGILNPVGKIAVWSELAGDLPPPVRFRLALWNCLIAAGLLLLFLWQGQSILSFFGIQLPAFKVGGGALLFITAVSLFEGKVKENFHLPQEGKSGPNPPSmtIVPMAVPLLAGPGTLTIAILFGLRAEGRGEFLQLSGVLLLSLFFVLGLLSVGPWLERRVGKPLLSALMRIFALLLAGIAAQLILEGLEPVISGV--
144 UniRef50_A3YU86 Putative uncharacterized pr... 132 6e-30 1 30.6% 9:214 9:218 --------HFMVQFVTSMVALLNPLGDFALFLALTQGRSRAEQKSIGNQAAVAIGVIMLTSLWLGRAILGGIGISIGAFSIAGGIVLFGIGLGMLngDSSKTESNQDNIDAGRMKTSPAVVPLAIPISAGPGVITALLVAssNEAGIPGLLALSVASVVMAGMMAVVFWYAPALGRLMGPSGMQITTQIMGLIVTAIASQMVLNGLKSAAPMFI-
145 UniRef50_Q2RRC7 Multiple antibiotic resista... 132 8e-30 1 29.6% 8:213 2:211 -------IDSLLSQITTLLVLVDPLGLLAIFVGLTAGRPAAYRRQVAIKGTLLATFVLVAFAVAGGKFLHLLGIDISAFRIAGGLMLLVLAHEMIFAKRtnESAKAMDKEMGGETSDPSVFPLAIPLIAGPGAITAVLLFseSDGTAIGLMWVIVAILAVTLPTLALLLTAGAVQRMLGETLTHTLDRLLGIILGALAVQFIISGAKEALGAL--
146 UniRef50_B9NS57 Putative uncharacterized pr... 132 8e-30 1 26.8% 8:212 1:209 -------MNNLLEHFVTLWVVIDPIGTIPVFIAVTAGIAAGARRKTALLAALVSAGILLFFLIFGQLVIEALDIGLNSFQVAGGIILFLFALTMIFGESKQAVEQRQAEEDADdkTNPAIFPLAVPSLASPGAMLAIVVLTDNNrsIADQSITALVMLAVIAIAFVLMLLAEPIIRLIGHSGAAIISRVMGMILASVAVNSVLSATIAIIKT---
147 UniRef50_A1VE68 Multiple antibiotic resista... 132 8e-30 1 23.1% 2:213 17:222 -MFQTFSMQDAFEVALPLFLIMDPVGNAAASLAILREHTPSRQRAIIRRELVFALAIVLLFHFLGDALLGLLDIEQSTLRLSGGIILFIIAMKMVFPP-------AQENDPEAVTRDPFIVPIAVPLIAGPSLLAAVMVYARQAqgMMGQASVLGGVLMAWGATALIMAFTPDLARILGPRAMRAMERLMGLILILMAVQMLENGIRIFVQSL--
148 UniRef50_A8HQV8 Putative uncharacterized pr... 132 8e-30 1 27.8% 7:211 4:205 ------DYDLFITQFVTLYALLEPIGHLSLFLALTGEHSKADRLRLAILSPLFAFAVLSFFALAGQTLLNAMNVSILSFQIAGGIILFSFSLSMIFGEAKKPSGVPEE----KNLISQAIYPLATPTIAGPGAILSVVLLanNRGSLIAQSMTVLAVASMMLLLMGAFLAGDIITRLIGSGGTNLVRRVMGILIAALSVDLVLSALAKWLH----
149 UniRef50_A3DKT0 Multiple antibiotic resista... 132 1e-29 1 30.4% 8:214 2:199 -------FDLLFAYYIQLLAIMNPFSALPTFLSLTDHLDEIERKDIVRKAFITSIILVILFSLIGNYILLAFGISIASLRIGGGILLLVIALDMLGGMPRTKQI---------EYSDIAVVPLATPMVIGPGTITTILLLTSREPGFLNIFLVLIASILAATTTFIMLRYSTKLVSILRVSVIRAIGRFMSLIIASVAVEMIALGIISFYHTYF-
150 UniRef50_A6SZ91 Multiple antibiotic resista... 132 1e-29 1 26.6% 8:210 6:218 -------FKAAILVPITMLPIINPFGNAPVFASLLGNVSRDVEKKLARQVALNCFFLLLGAMFIGSHVLMFFGISIPIVRISGGLLVAFTAWRLLNDNGQDAIRTQVATAPMEAWSdrSFYPISFPLTVGPGAIAASITLGASTpqVISLGSAAVGAAMTAFVIWLCYNSANKMVKMLGRLGTMVMLRLSAFILLCIGVEIFWTGVVGLL-----
151 UniRef50_A4X2W3 Multiple antibiotic resista... 131 1e-29 1 24.4% 6:214 1:201 -----MDIKLFGEVFVTLLVIVDPPGMMPIFLALTGPLSARDRHRAAWQAVALALGVIAIFAVAGSTLLDYLHVDLPALQ--------AAGGLLLVLVALELLTGKADDPSQQATSNIALVPLGTPLLAGPGAIVATMLFMQQADGAADITAIAGAIIAVLLAVWVVLRFSGGIVKILRPGGIEVLTRIAGLLLAAIAVQLIADAVAAFVTQYT-
152 UniRef50_A9HK24 Multiple antibiotic resista... 131 1e-29 1 28.4% 9:209 22:232 --------DTFLLAFPALFSIVNPIGASLIFTQVTAGRARAESLALARTVALYSAVLLIASIWIGSAILAFFGITIDSLRIAGGLVVAVRAWALLQAPEEAAARKEQqtVAVPRWTEMAFFPMTMPFTVGPGTISVAIALSAGRPASSgyVALSLAAIVVAGTIWLAYAYAERLMALLGVTGARIVSRLAALILLCIGVQILSAGIKGL------
153 UniRef50_B9M3N7 Multiple antibiotic resista... 131 2e-29 1 27.1% 10:212 2:195 ---------TFYAAVILLLLVMDPLGGIPFFISALKNVPEHRKKKVILRELLIALALMILFMFQGTKILKMLSISGPSLTIAGGIILLLIAIKMIFPS-------KDEFMENVVGNEPLIVPLAIPYVSGPSALITVTLIMSREPHRWKEW--LLALLFAWVVTGSILIMCTELERLLGERGVIAIERLMGMILTTIAVEMTLNGIVAFLAQ---
154 UniRef50_B6IU07 MarC integral membrane fami... 130 2e-29 1 27.5% 9:208 3:207 --------DLILATAVAFLVTIDPIGLGPVFAGLTAGMEHSVRRRMAVKGVLIGAGLLFVFALVGEGLLKALGIGVGAFRIAGGILLLLLAIEMVFARESGIRATPDERAEAQDkaDISVFPLGIPLIAGPGAMTSVVLLMGRagDLASQAVVLGVLAAVLALTLVVLLFAAEVSRFMGVTGINVVNRVLGILLAALACQFVIDGLIE-------
155 UniRef50_A7BE02 Putative uncharacterized pr... 130 3e-29 1 27.8% 5:209 2:203 ----MTVLAGMSAAILALAPITNPIGGLAAFAGLTAGNAAAAVRSQAWKTGIYVFAILTVFAVSGSLIMRFFGFDLPSLQIAGGLVVSHSGFSML---ENKRRATHEETQHATSKPDVSFSPMALPLIAGPGSIGVVIALAARNTAIGFHVGIVLGIAVTAAVIALLLRYGTPWIDKLGATGVGAIVRIMGFLILVIGVELIIHGVRAL------
156 UniRef50_Q4FNW7 MarC family protein n=2 Tax... 129 9e-29 1 30.5% 8:210 2:201 -------LEIFIQTFFLYFIVIDPLGNTPLFLAVTQNMSSQQRVKTALSATIIASIILLFFAFLGSTLLNYLNISFPAFTIGGGIILLIISMEMLFDK----RQQRKEDDIDFNSENVSVFPLATPIIAGPAAITSVIVSVSDMGsfTNQSVGMIALASVLLLTFIFFFTASKFSQIINKKVISVISRVIAIILVGLSVQYILDGIKTFL-----
157 UniRef50_Q8K9B4 UPF0056 membrane protein BU... 129 1e-28 1 22.9% 8:212 1:196 -------MNEIISTTILLILIMDPLGNLPIFMTILKKLDAKRRRIVVIREMIIALIVMLIFLFVGEKILTILNLKTETVSISGGIILFLIAIKMIFPSDEGNNGTSSE-------EEPFLVPLAIPLVAGPSLLATLMLLSHQY--LHHMPYLVGSLLIAWFFTIIILLLSGLFLKLFGDKGVNALERLMGLILIMLSTQMFLDGIKAWFKN---
158 UniRef50_A8ZZM6 Multiple antibiotic resista... 128 1e-28 1 28.2% 9:210 3:196 --------HLFLSLWIKLFFVFTPFFGLSMFLSLTEGYDEPRRRRVALTVSLAVAVLCLLLFFGGRQIFSLFGITLDAFRIGAGALLFLSGVGLVQGKPVNAG--------VASGSELAVVPLAMPIIVGPATIGILMVMGAELEGVREKMAGCMALLAAVACITVVLLMGSFIYRRLGAMGIGILSRLTGLVLAALSAQMIMTGIQAFL-----
159 UniRef50_B0U0F2 Multiple antibiotic resista... 127 4e-28 1 30.5% 8:210 7:207 -------IAVILKFIISLFAIINPFSLAGIYLDTVKQSDQKEKNTIVFTMILAFLAILSLMVWFGNNILSIFGINQDAFRAGGGVIVLFFGLRILGVLAQPVSDTTVKIVSAR---DLAVVPLAIPLLAGPGTIATVITDSHEyaTIESKVIANLCLLFVAIVLWLFFRYLPKISAFLGEHTIDVISKIMGLMLVAISVEMIFDGIKGFF-----
160 UniRef50_D1N0K9 Multiple antibiotic resista... 126 4e-28 1 28.1% 8:210 1:197 -------MDTFSSMLILFFLVMNPLGNLPVFIAELDRQPPERYRFIVLRECLIALAILLLFVFCGGEILKALRITQASLELAGGIILFMIAIKLVFGSASGSGEKKSAPES-----EPFIVPLAIPLFAGPAAMSTAILVGGR-GGFMHTLEAAGALAAAWAICTAILLSGRYAGKFLGAKALSALESLMGLLLTTMAVEMIIAGIKYAF-----
161 UniRef50_A5EYD2 MarC family membrane protei... 126 4e-28 1 24.6% 10:204 2:191 ---------SLTAAILTLFLIINPLGNVPVFLSILKNLSPKRQRIVLLRELCIAYAIMVVFLFGGSSILHGLNISREAVSISGAIVLFIIALRMIFPLRSGSVMGAD---DTEGEEEPLIVPIAIPFVAGPSLLATLIMMVESDPSLTTRW--FFAMTISWFISLLIFLCAPFFFKILRKRGLKAVERLMGMILISISVQMMLN-----------
162 UniRef50_D1JAE0 Conserved hypothetical memb... 125 9e-28 1 32.3% 10:210 10:200 ---------LLAKSFIMLFVVMDPPGNIPIFMALTKGMSGGERKKELNHAVVVATILLLLFAFLGTMILYVLGITPDSFMIAGGILLLLI-------SFDLLRGEHKYGTSGDSGAGVGAVPLGTPLLAGPGAITAVMVLMQEENGV---FIALFAIFTAIIATRFLLGQAERIYSIIGKVGSEVLSRVIGILVAAIAIEFIAKGIAGMF-----
163 UniRef50_B2UQV9 Multiple antibiotic resista... 125 1e-27 1 22.3% 8:209 1:198 -------MQDFLSTVILLFIVIDPVGLAPMIQGMLKKYSPAQQKAILTRELVFALSLLLLFFFSGKFLLNLLGLEPSTLSISGGILLFLVALGMVFP----AKDMLSSSGRADGKDEPFIVPIAMPLMAGPSSLSIIMLHASQTPDSISQMTYAGAIVTAWFLSGMVLFIAQKFLRLLGEKGTIALERMMGMVLIMISVQMFMNGLAGY------
164 UniRef50_A8A8R0 Multiple antibiotic resista... 125 1e-27 1 22.6% 6:213 1:195 -----MDLNAVINAFISMLIIIDPFTNAPIFYQLTSSFEPKRRKRIIVRSATVSTIILLVFALFGDLIVRPFGMTLEDIKVATGLILLIYAIQALLGKS---------EAEMIDPESVAIVPMAIPMLAGPGAISLVLYYRSVLEPYE----LALVVVGVMLVSLPILLLGGYLDKLLGKNGTLALNRILAILMAGLGIAMVREGLLTFIRPV--
165 UniRef50_D1R808 Putative uncharacterized pr... 124 2e-27 1 19.2% 6:213 1:198 -----MNDLSLFSITLVLFLIMDPLGNIGSFREMLKRIDPKKQKIIIMREMLIALFTMLVFNFLGEVIFEYLQVTETTVQISSGIILFLAALKILFPSKDSPRSNLPQ-------EEPFIIPLAIPLVAGPSLLATIMLYAHMETSVP---LMLGSIFIAWGLASIILLFSNRLYTVLGNNGLVAFEKLMGMVLILLAIQRFLEGVENFVKTL--
166 UniRef50_A1TTZ1 Multiple antibiotic resista... 124 2e-27 1 21.9% 9:209 11:219 --------KSFLFVIAALLPIVNPAATAPIFLGLTEGASPTTRALLARRIARNMFWLLLGAMLVGSYVLEFFGISLPIVRVGGGMIVAATAWRLLTATQadSRTELAESFTPDMARRQAFYPLTFPVSCGPGSIAAAITVGVSLasLARMGGGVLALLSVAVLLYFAFRYAQQLLKPLGEAGSVIFLRLSAFILLCLGVQIVWDGVYEL------
167 UniRef50_B1Y4J7 Multiple antibiotic resista... 124 3e-27 1 27.6% 26:210 20:196 -------------------------GSIPIFISVLKGVAPERRTRVALREALIAFSVLAVFMVSGQHFLTLMRLSERSLEVAGGVILIIIAIRMIFSGGSEIYSQDGEPRE------PFIFPLAVPLLAGPSAMATVLLLASRQPDR--LLDWAGALTAAMAICATVLLLAERIRKLLGDSMVSAIEKLMGLVLTAVAVEMILAGLKRYF-----
168 UniRef50_D1R807 Putative uncharacterized pr... 123 4e-27 1 22.9% 6:210 1:195 -----MSGQSIFSIALTLFLVTNPVGNAPAIIALIKDFDFSRQKAIMLREATFSLLLALFFQYFGEVFLNTLHIDRYTVSLCGGTLLFLISLSMIFP-------LHHEETVKATKHEPFFVPIATPILSGPGLLAMIMLLSAQVSSN---FAMSLAILLAWVGVFFVLLIAPYLNRVLGKRGLLALEQLMGLVLSIISTDMLVKGVEQFI-----
169 UniRef50_B1YA24 Multiple antibiotic resista... 123 4e-27 1 24.0% 1:208 1:196 MTNLGSDLMELLTAVVALYVIVDPLGNIPLFAALTAGLSEAQRSRVLLLSVLVASAVLVLFAVFGVEIFGYFGVELGDFMIASGLILISFSLH--------QLIRPYEQRPATDGLEVAVVPLAVPYLAGPASISYVLLMSKHMG----VAPTLLAVAAVSLLTFATLRASGFIMRALGVLGIRVVEKIMLILSVAIGVSLVRRGLEA-------
170 UniRef50_Q6MDE2 Putative uncharacterized pr... 123 4e-27 1 17.8% 11:212 3:194 ----------IFNIALVLFFIMDPIGNISSYQTMVKELDRRHQSKIIFREMLIALVAMIFFNYIGEFIFDFLDLSETTVRLSSGIILFLIAIKILFTANDSPRANLPQG-------EPFIFPLAIPLIAGPGLMATIMLYAHLEP---YQSIMLASILIAWTLSVIILYFSKKIKSFLGESGLMASERMIGMVLVLIAVQRFLEGILLFWTT---
171 UniRef50_A6FM96 Multiple antibiotic resista... 123 4e-27 1 24.4% 7:207 4:202 ------SLAHIMEEFAMLFAVVDPIGTIPVFLAIVISLPEEKRSSVAFKAVLIAGSLLLFFIAFGQMFLEAIGVSLSSFQLAGSLVLLLFGLNMIFG---EARQDSEIGLAEKSDVELAVYPLAIPSIASPGALLAVVLLtnRTTPILEQVITTGLVLVILMMTLACLLLATRVHKIIGNAGSSIISRVMGLIISALAVETGLDALS--------
172 UniRef50_A3DL90 Multiple antibiotic resista... 123 4e-27 1 29.3% 6:210 3:194 -----IDVYQLVSAILMLFVVLDAPGNAPLFYFFTKDMEPWKRIYTIRKSIIVAAFILLLFGLFGDYILLYFDITVNDFRIAGGIILFIYAVLGILGHTT---------AEEVSGEEIAVVPLATPLLAGPGSITVVIYLKYSMG----LLLTMLSIAINMIIAWILLENGGKLLQLLGKQGSTVLSKILAILLAAYSVAMIREGIISLI-----
173 UniRef50_A1SV44 Multiple antibiotic resista... 123 5e-27 1 29.9% 8:208 2:204 -------IETAGLALATFFATIGPLDVAAVFAALTANQTDQQKRTVAIRGTLIGTAILVAFALVGELLLSSLGISLAALRAAGGILLLLIGIDMVFARSsgTSTTDDEEKEAISKTDISVFPLATPLIAGPGAMGSAILLMaqHGDLTGQVIIIFSLLAILFLTFISLLLASKLQNLLGITGMHVITRVMGVLLTALAVQFIFDGIKQ-------
174 UniRef50_C6QAI6 Multiple antibiotic resista... 123 5e-27 1 31.3% 8:208 2:204 -------LETALKSLTTFFATIGPVEAAVLFATLTPKMPRAERQAIAIRATLIASAILAFFTVLGGPILAQLGVSVAALQTAGGIILLMIAIDMIFARPGGakLTPPEGAEAQTREDVAVFPLATPLLAGPGAMSAGILLTANASdpFGLAIVVASLACVMIATLALLLLAQELNRVMGITAQRVLIRVFGILLAALAVQALFNGIKD-------
175 UniRef50_B2TBL8 Multiple antibiotic resista... 122 6e-27 1 23.6% 8:210 6:214 -------ISDILFGFTGLISIINPIGIAFVFLDRTASLTTEERTALARKIAINVMCVLLVAFFIGTPILHFFGISMQALRIGGGLAVAVGGWQMLNAPDTQPAEKPakRVDADNAMSKAFFPFTIPLTTGPGSIATAVALTANRThvISSIASVVISVTVAVTVYLVYSRAVVFAKYLGVEGTKVAMRVSSFLLLCIGVQIMLTGFSEFL-----
176 UniRef50_B9KCI9 Integral membrane protein, ... 122 6e-27 1 21.3% 6:212 7:210 -----SEIYIILLASVAIIAVLNPFGNLPQFIAMTEGLDADTRKKLFRNIIYTAFCIVLVFLLSGPFIMKyfKIDINDLRVAGGLILIIMSTKNLLFTPSSSQFQHYQGLSHKELLKKSIVPMAFPMLVGPGTLSTVVVISED----QNLAIAIASVLLTFAFIFALFHFSATIEKVIGKLVLYVFSRIALVFIMAMGVKMIAIGVQTYIQS---
177 UniRef50_Q4LEJ1 Integral membrane protein o... 122 6e-27 1 26.3% 6:210 4:194 -----LNTDELIRASVSLFIVMDPIGLVPLIASLTSKLSIEQSRRVVRSTIYTASALLLAFAIAGHYILEAFGISLSSFRIAGGL----------LLLLLSFELLLKGWELKGNEISIGAVPLAFPLLVGPGAITTILISLDRYG----ILVTMLSVAIVLALTMLTFSFMNTLNRLLGNLGSLIVSRVMAILIAGIAIEFILSGVEEFI-----
178 UniRef50_A2A0C4 Membrane protein, putative ... 122 8e-27 1 24.3% 8:213 1:203 -------MSELINSFLFLVAVLDPIGSVPVYLEATKDFDKKHKKKIAVRASFIAFMILLAFIVIGQFFLEGMSITLDAFRISGGLILFLFSLTMIFGESKPES----EKQLITDYKHVTIFPIAIPSIASPGAIMSVVILTDNhyTIEQQIVTTLLVALVVFLTALILLAAVAVQKRIGDYGIIIISKVMGLILASYAVQNILSGLKNFFMSV--
179 UniRef50_A1U7B4 Multiple antibiotic resista... 122 8e-27 1 27.8% 8:212 6:206 -------FSTYLSSTIRFLFLLAPFFVVTMFLALTRGLSMAEKTSIIRRACVSAFILGVILFFAGPLLFNAIGITLNSFRIGAGSLLFLTAISLVNSGTRN----HATGLPEEDRDDIAVVPLAIPVMIGPATIGAIMVYGAELKAVPEVAGGLLGLVSGLMILAGLLRLSGYLEKALGKTGLNIMSKISGLILSAMAAEIVLTGIAGFIAS---
180 UniRef50_B1ZVN7 Multiple antibiotic resista... 122 8e-27 1 25.9% 11:207 8:192 ----------FLQAFIPLFVAIDPIGLAAIFLALGTGVPLEQRRRIARQAAWTGGGVALLFLLLGQTIFGALGITASDFQIAGGLILFIIA--------ARDIMHSAAEAPAKLADDFGVVPLGMPLIAGPASITTLILLAQTVGVW----ISLAALAVNLVLIVLAFAYSDKLGRLIGATGMRAISKIISLLLAAIAVNMIRQGVA--------
181 UniRef50_A6VX13 Multiple antibiotic resista... 122 1e-26 1 22.2% 5:211 1:197 ----MSAEFSILSATLLFLFVIDPFGNIPILLSVMKGVPQKRQYQIVVRDGLIGLVILVCFLFFGAEFLALLHLETESISIAGGVVLFVIALKMIFPSPYTKDAGP--------VMEPFIVPISIPMLAGPSTLATLLVMVKSYPNDQQNL--LISVGAAWAISVAILAMAPLLNRILREKGLAALERLMGMLLLMMSVQMLVNGVRSLFT----
182 UniRef50_C2BT16 MarC family multiple antibi... 122 1e-26 1 25.8% 7:215 12:214 ------ELGLFISTFTTLFVIIDPFGNLPVFMSLTKDLPKKQRQTVALQANLLAIVILFVFGFFGFQLFGLLGISPAALQISGGLLLLI-------VALQLLTGAEGTVGEEGGSLNIAAVPLGTPLLAGPGSIVALMVAMGNahHPLSVIAVASGAFAVMFASWLAMHFATPIIHFLGNSGVAVMTRLAGMLLAAIAVELMISGVISVVQDVAK
183 UniRef50_B2KBR5 Multiple antibiotic resista... 121 1e-26 1 22.7% 8:210 1:193 -------MEFIFSAVFTLLMVMDPFGNMPIFITALRKVSPERRRFILIRELCIALLIMLAFVFLGRQFLGMMGIKEYSLSIAGGLMLFIISLKLVFGSSEDPGANPKD-------EEPFVVPLAIPLVAGPGSLSTIMILSAQSPS---KSIIWMAVLIASALNLIILLFSFPISNLLGRRGLLALERLTGMLLVLLSVNMVMSGVADFM-----
184 UniRef50_C3WBK3 Integral membrane protein n... 121 2e-26 1 19.5% 1:210 1:206 MKGVTMRVDAIFINALTLIAVLNPFGNVPLFIGMTEGMEKEIRNKLFKMIAITGFFITWIFSLFGEFLmnFYKINMNELKMAGGLILILMAIKNLIFSPQRKRTSEKQLSPDEQIKQ-AVIPMAFPMLVGPGSLTTALIGRSENGLTSNSF----SILVAFIIIYLVLMVGNYLERIFGKLVLYILSKVMQIFIMSIGFRIFFDGLSHMI-----
185 UniRef50_Q5UEW8 Membrane protein, putative ... 121 2e-26 1 28.7% 8:209 2:204 -------VTELVSLALIYFAVIDPIGTIPIFLSITERFDYKQKQRVALRGCAIAFFVLVFFGFFGDLILSHLKISSATFNIAGGAILFLISMEMVNGRRQARKSQAVerVSAEELIRISSSPLGVPLLAGPGAITSIMVFG-DFTSLDKLVINLSSIFIALAASALLLYLAAWGSKFINLTISTVMSRLVGILLAAIAIQIILNGLNKL------
186 UniRef50_Q31NH4 Multiple antibiotic resista... 120 2e-26 1 33.5% 6:214 1:218 -----MSFPSQAAFATTLFAMLNPLGMLPVFISYTESERRQVQRWAALFISLTVFALLILFLLTGSTLLRFFGISLSSFRIAGGILLLLLGINLTIDNTAKqhEQESSLRAAESVYKKIVIPLAVPLLVGPGAIANVILHGTLAETEQQYGLlaLIIALISLLTFIIFQSGRWFQKVIGDVGLSILTRILGLLVAAIGIQFLVAGVADVAATVV-
187 UniRef50_A8YHS2 Genome sequencing data, con... 120 3e-26 1 29.0% 6:188 1:192 -----MEWSFLRNFAITLFALLNPLGMLPIFISYTARERKEVQRLVALFVSLTVLCLLLIFMFIGTAMLKFFGVTLDSFRLAGGVLLLIIGINIVNGSGAGTkqGGDYLSEAKSVYRQIVIPMAMPLLVGPGVIANVILYASEAEsrGTSIELILMTILVSFLVFLILAAGKWLQRLLGDIGLSITQR---------------------------
188 UniRef50_C6X1I7 Multiple antibiotic resista... 120 4e-26 1 26.2% 2:215 1:197 -MFEYFSLKETLTATMVLFAVIDIVGSIPIIVSLKKRFGHIE----AGKATLAAMFLMIAFLFIGNKILKFIGVDVNSFAIAGAIVIFIIALEMILGI---------EIHKNQEAKSASIVPIAFPLIAGAGTLTTTLSLKAEYHDIN----IICGIILNTLFVYLVLKSANWIERKLGEGTLQVLQKVFGIVLLAISIKLFTANFAQLFSSYVN
189 UniRef50_A5FPP7 Multiple antibiotic resista... 118 1e-25 1 28.2% 6:207 3:191 -----DFWNNILLTFVPLFIVVDAVGNLPFVISITDQSTAEERKKVVNLAVITASLLGLLFLFMGKLVLDLMGISVGAFAIAGGLILLLFAIRYM---------TSGHMVEVIKEEMVAVVPIGTPLTMGPATITTLILLVNQFP----LYIVLISFALNMLATWLIFKSSQWFVHYMGRGGLKAMSRIFSLFLAAIAISMIIKGLR--------
190 UniRef50_A4XNM2 Multiple antibiotic resista... 118 1e-25 1 24.0% 11:210 3:193 ----------IFSIAVLIFLVTDPFGNIAIYIAALKNVAPRRRLWIAARELLFALGLLLLFLTFGDKFLSSLGLSREATAIAGGIILFVIAMRLIFPSPQGLLGDVPDGEPM-------LVPLATPAVAGPSALAVLMTLRNTHTGP--LWELYLAVILAWAATAFILLQASFLQRFLGNRGLMAVERLMGMLLIMLSVDMLLDNLQSVF-----
191 UniRef50_B5YIN6 Putative uncharacterized pr... 118 1e-25 1 26.2% 5:210 1:193 ----MEILNTFLLTFIPLFVAIDAPGILPLYISLVEGVPDKERKHIARQSVITAFLVGTLFLFLGNFIFSLLGIKLEDFMIAGGILLLILSISDIL---------RVKEKELTISDTLGVVPIGTPLLAGPATLTTLIILAGNYG----YPIVIFSLSLNLLIAWVMLEKAEFVIKVMGIHGIKAFAKVMALLLSAIAVSLIKKGLTKIL-----
192 UniRef50_A1SUW5 Multiple antibiotic resista... 118 2e-25 1 24.6% 8:210 2:197 -------LETFFTLYLKMFFMMTPFFVLSIFLSLSKKLSNPAKKVVILRSSIAVAVAGLIFLLFGKYIFSLFGITLDAFKIGAGTVLFLSALEMIKGGEVPENTMKKGS-------DFAIVPLAIPSAIGPGLIGVLMVIGAEMSGVLGITLVILSLLAAVISLAGVLLLSNKLQDLIGEQGLEIIPKITGLFVSAIGAQIIFSGIQGFL-----
193 UniRef50_B9L924 Putative membrane protein n... 117 3e-25 1 21.4% 11:211 3:190 ----------ILHIAVTLFLIMDPFGNFPVILSLLKDYNDKEKLQIIIRELIFAFVVIFIFIFFGKNIMNFLGLREESISIAGGIILFLIALKMIFPSSDPMFGKENE---------LYLVPIAIPMIAGPSLLATLILFSSQYGISEVLGASLISWTLSALIIIISLKFS----KIIPNRVFSAVEKLMGMLLISLSVQMLLDGIAKYLH----
194 UniRef50_Q9Y8Y7 Small neutral amino acid tr... 117 3e-25 1 23.2% 5:215 1:199 ----MADLYTVVSSIILLFIVLDPVGVSPYVASIVARRPEGERERIVRTALASAGAILVAFTLIGVAVLDILGVSMDEFKVAAGLLLLIYATADLFEI--------KIGYSEPSGDEVAIFPLATPLLAGPGSIATVMYIMGSSG----IAVALIAILVNLVLAYPILHASLKLVRLLGRHGSLLVAKFTAFLMVGFAVSIIFDGLRGIVPGVFS
195 UniRef50_A1S0Q7 Multiple antibiotic resista... 116 6e-25 1 23.4% 5:209 6:198 ----ADTLFKSLFVAVQLYAVLNPVSVIPTFVNLTEGLDSREKVHAVRKASMIVFSLMVVFSLIGDPLLRLLNVSIASLRLGGGVLLMVIAVDMLSGMSRTKG--------LESGDEALVVPIATPLLVGPGTITTLIVLSASEG----LPVTLLGALLATLLVYATLAFGESLLELLGRNFVRSLGRFMAIIIAGISAEMIHRALLEW------
196 UniRef50_A6Q130 Multiple antibiotic transpo... 115 1e-24 1 32.4% 8:211 6:213 -------ISILLHDIIALITIINPIAAASIMISMISPPTASAIADVARKATLTVFAASFVTLFGGEVVFQFFGINIYSIKIIGGIILMLIAINMAYGHGAKNRHSPEEAQEAQEKEDIAIVPLGIPILFGPGVIATIVVlsSQLHPALSYILLSIAILIASLATYLTLRYASIINKALGVTGIKILTRIMGLIVGAIAAQFLISGIKGLWE----
197 UniRef50_A7I7F8 Multiple antibiotic resista... 115 1e-24 1 25.1% 4:214 8:226 ---YMDQGTFFVTSLAALFAIINPVGNIPFFIMYTSEisPRTRQAVAVLLGPVIFVTVLLCMFFGSAVLSFFGVSMPAFEIAGAIILMIIALSMISGTRTEQVHAATSSeaAEAYIPKIFIPLIFPIYIGGGTIAVSVLYGNDALTGGFLAAAIGVTAIICIIIIACNLASDAITRVLGKQGLEIVARLVGVLLLGLAVQMFATGAGEMVATFI-
198 UniRef50_B2J6W5 Multiple antibiotic resista... 114 2e-24 1 29.8% 6:210 1:195 -----MDISILVQTFIAVFVLADAVGNIPIVLVLTKGMMPDQRNKVIDKAIIVAIAVLLLFAFAGQVILNYLEISIGSLRVAGGVLLLLIALQMLRGELDQPII--------EEGRDVAITPLALPLLAGPGTLTTVMLLMSKSQSPH--IAVAVGILGAMFITWLILRLANLIDQWIGAEGGVIVTQLLGFLLAALAVEIGSTGIRELF-----
199 UniRef50_Q6L037 Multiple antibiotic resista... 113 4e-24 1 28.4% 16:209 1:184 ---------------MPLLVVIDPFGSLAIFVSMTASYNKDTKLSISRDAVLYGGMILIIFAALGEIIIQFFGISIEALEIAGGIILLLMGIEMVREGAK--------PESSSGSKNLGIVPFATPLLAGPGAISLVIILMK--GSLTTKIFTIVSILIVLALVYIFFIFSSKILEILGEKIMTAITRIFGLLLAGFAIQYFLDALISL------
200 UniRef50_D0MK78 Multiple antibiotic resista... 113 5e-24 1 25.9% 8:212 1:197 -------MNAYLETFLPLFVAINLPGILPFFIALTEGLSAADRRRLLVRAVATAFVVAVLILFAGQLIFETLGITLNDLRVGGGLILLVLSIT----DLVFADYRRRDPRDGADAADVGVVPLGIPLIIGPAAITTILV----AQQTYGYLPTLVSLVANLLLVTAAFAAGPWVIRKLGPVAVRAIAKVASLFLAAIAVAMIRAGVAGMLAG---
201 UniRef50_A1RZF3 Multiple antibiotic resista... 112 6e-24 1 28.8% 1:212 15:213 VGFVVESLKELWDTFLMLFIVVDSIGNIPIFYSLTSGMGREERIKIFEKSVAVASALLVFFAVFGYPFFQYYGVSFTDFKIAGGLLLLIIALQGVFGRV---------EAEALRSEDLAVVPMATPLLAGPGAIYMVMYL----NSVYGLLPTLVSIALNTLASYLILTKSNVLLEKAGKNTILVLSRIFSLLLAVLAVSLIRSGIYEALRG---
202 UniRef50_D1RJ36 MarC family integral membra... 112 6e-24 1 25.6% 5:211 2:221 ----MVLIQAIFFSFAALFPIVNPVGASIVFLTLVKGSSRQQINALAIKISIYTVVMLLLVLVVGSLILSIFGITVPIVLISGGLLLTQVGWQMLygLSSSASQGKKISQLKSIEDPRAFYPLTLPVTAGPTCIAITIALGAheSKFLAMLGYSIGIILIGLSVFFCYRYSYYIFDKLKDAGKNVVMSLAAFLNICIGLQIIWRGIEMLIP----
203 UniRef50_Q3A045 Multiple antibiotic transpo... 112 6e-24 1 25.6% 21:215 20:205 --------------------VINPLGNIPVYRDLTSGMDFSKRRAMIQLGVGTAAAMIIGFALLGDWSlnLFEVTLDEFRIAGGILLFIVAVRGVMTGSLSYN------LLSDDFRTRAIFPLAFPIIVGPGTLAVTIILAQNRPPLHMLAVSSVS----CIIVYLIASSAHSLMRVIGGYAAMIIPRLLYIFLAAKAVALIMHGLTGYVQGLLK
204 UniRef50_Q6MDE1 Putative uncharacterized pr... 112 8e-24 1 22.9% 10:214 2:196 ---------SVIQLAMIFFIVTNPIGNCPTIITLIKDYSIKQQQKILFRESIFSMILAILFLFLGEIFLTSFQIQNYALTISGGILLFIVALKMIFSDRLKTKT-------DTPKQAPFIVPIATPLLSGAGLLTMIMLYSKEEAND---LKMLCAILLAWVGITTVLVTAPYLQIFLGKRGLAALEQLTGMLLAMIAIQMIVQGSGLFLTLLF-
205 UniRef50_A3ZTD8 Putative uncharacterized pr... 112 1e-23 1 26.3% 6:210 1:201 -----MNFELLFGEFLLLIATIDPIGTLSIFVGVTGKSPKEDRPRIALKATLIGGAVLLAFLVLGQFILGALDIRLESFQLAGGLILFLLGLQMVFGVGP-----AVEAPKAEAGHDVAVFPLALPSIASPGSILAVVILTDNHrtMLEQAVTAVVLVVVLGLTYVLMLAANPIHRLIGDTGGMIIVKVMGLLLCALATENCVEAVQQLW-----
206 UniRef50_C7LYJ4 Multiple antibiotic resista... 112 1e-23 1 29.4% 6:209 1:197 -----MVTKFFVEALVTLLVIIDPIGNIPTFLVVTRGRDQRARRRLATEAVLVAAAVLAVFALAGSQILDYLGISIPALEVSGGLLLLIVALELLTGRGGSIGTTEEGI-------SVAVVPLATPLIAGPGAIAAVLVLAKRAATAPLSVALAGALVGSMVILWVVLHYASALVRILKESGIALLSRVFGLLLAAIAVQLAAEGIRGF------
207 UniRef50_B1TBT7 Multiple antibiotic resista... 112 1e-23 1 21.9% 24:215 21:212 -----------------------PPVAIPMYAAVTGHFPDATQRQIAFRLFAWIATLMVGAVWGGQFLLRMLGLTLGALTLTGGLVLCLWSIPMMRGTANDERSGGDTRLEYAQWRNYIAVPLIFPLSIGSAVMSLVITTATRFHTPVDLLALSAACILHAGVIGLTYACSASWCRRLGEIGRTLIERLSGIVLTAIAFQMLAQGVRELLPGLAH
208 UniRef50_B7VQK4 Multiple antibiotic resista... 112 1e-23 1 30.0% 8:210 11:213 -------FTYMTLTVLGLLPIMNPPAAATVLLGLSKGRDKSYIVSQAKTTGVYLFIALCITFFIGASVLELFSISIPSLRLGGGIIIVAIGFNMLFPR-------PDNGAAPSGQDSIALVPLTIPSLCGPGSMAMIISLAAQIATYEnyGGVVAGLALVALIATFTLTMAYPLLKALGQNGINAFTRIMGFLLICMGVQFFTLGIQEIV-----
209 UniRef50_Q2LRX6 MarC family integral membra... 111 2e-23 1 27.1% 8:210 1:192 -------MKSFWLCFVPLFVAVDAVGILPLFMSLTEGLETRKLRRIISQSVITAIAVALVFLVLGKALMDLLGITIADFMVAGGILLFVISLNDVLA-------TEKAQQHTVDPDSLGAVPLGVPLISGPAVLTTTLLLSNSYG----FVPTATALILNILLAGGVFFSSRIIYRFLGKTGAKTISKITSLLLAAIAVMIIRRGLFIIL-----
210 UniRef50_A5ETX6 Putative multiple antibioti... 111 2e-23 1 27.9% 6:213 3:197 -----STLEFVITTFVTFFVVIDPLGILPIFMALTGKKSVAIRQQIAVRAVLLAGPILIVFAFAGDTVFRFLGISLPAFRIAG--------VPADYGLQPRPKKTRQSKARTWRFFHLQYR------SAGPGAMTSVILIMGKAGSDFLIQLIAMslLSVLLLCLLVFLFASRLMAVLGLTGVNVIGRVFGIVLAGLAIQYMLDGFAAYIAIL--
211 UniRef50_A7I5R8 Multiple antibiotic resista... 110 3e-23 1 24.2% 2:208 5:199 -IDMTDIISGIIYAFAALFIILDPILSVPIFAGMTKGQSAREIHKQAFIAVAVAGILMYIFLVFNTAIFSVLGLTLSTFQIAGGILLFLLGMEMALGIDLCKSKEQVPTA--------AGVVIGTPLLCGPGAITTVMLLSNDYG----ILIPFIAISLSLAATWVILYYSAAIQNILGTVITDIMGRVLGMLVAGIAVKIIFSGIIG-------
212 UniRef50_Q89Z73 Multiple antibiotic resista... 109 6e-23 1 20.5% 2:211 1:220 -MSLSSLLIIFSSSFMALFPVINPLGNGFVVNGFFADLDPSQRKTAIQKLTINFIMIGVGTLLIGHLFLLIFGLAIPVIQLGGGILICKTAIELLGDSNSSDKEGTSQNVDSFKWKSiiFYPITFPISIGPGSISVIFTLMASahTGINYLVIALVIICMAGILYVFLSQGQRIIQKLGPVGNQIINKLVAFFTFCIGIQISVTGISQIFH----
213 UniRef50_A5GU87 Uncharacterized conserved m... 109 6e-23 1 26.0% 6:213 1:215 -----METSSFQHYLIGLLAIGNNVSALGAFLLHTQGMPRAKVKRLILMSGLACLITLVLFMVVGTRILDFFGISVSAFQIAGGLLLGGVGLEMMNSRTPLPTGAAASAasDAQFYSAAVVPIGIPLTIGAGTLSAVVLFAETAYRSGTALNLLGAILILVLVNTAIFRFSSRIMAWLGEVGVTIFIKLMGLFTLAIGVEFLTKGLGAIYLNL--
214 UniRef50_C2M291 Putative membrane protein n... 109 7e-23 1 25.2% 6:211 1:189 -----MNLEHIAQISFKLFWIIDIIGGLPIFISLMNRFGKIQTEK----AALVSACLMIIFLFAGEAMLRFLDIPLKVFAVAGAFILFIIAVEMILGVSFHK---------MEEANSISIVPIAFPLLAGPGVLTMILSLHSSYSSVD----IVISILINVAIAYVVIKHCRRINDWMGQTGIVIANKIAGVILLALSIKMFADNWKTIFE----
215 UniRef50_Q467G3 Multiple antibiotic resista... 109 1e-22 1 32.7% 58:210 1:153 ---------------------------------------------------------MPFFAVTSNIILELFSISVDSLRVVGEILLFSIAFDMMHAKISRESITEEDISQSQEREDIWVFPIGLPLLIGPGEISTVIVLMGSTENIEHKIIILISIIFTFILCLYIFLLSRRIHKFIGYNGMLVFTKLMGLLLAALAVNLTSAGLKNIF-----
216 UniRef50_B7K783 Multiple antibiotic resista... 108 1e-22 1 20.3% 10:206 91:285 ---------SAFNLFIIFFVTLGPIKIIPTFVRLTQKADKNFRCQLAFISATISTIVIVFVAIIGQNILKVWQIRLPALMITGGILLFLVALKIVM---SQYNLSPKAESPENPSLDLAINPLVFPTILPPFGIAIALTFMVMSPQLgsSVITLALLLLVMGLNLICMLAAHPILSFIKPVTLLILGFILGVMQLALGIEFILSGL---------
217 UniRef50_A5FMK4 Multiple antibiotic resista... 107 2e-22 1 24.4% 6:210 4:191 -----IDFKEIITVSMVLFAVIDIVGSIPIIVNLRAKVGHIE----SEKASIVAGAIMIVFLFVGEGLLNLIGIDVHSFAVAGSFVLFFLALEMILGIR---------IYRDEEPGSASIVPLAFPLIAGAGTMTTLLSLRSQFHTIN----IITAIVLNIILVYIVLKSSKKIENLLGENGLGVVRKTFGVILLAIAVKLFAANVKGLF-----
218 UniRef50_C2M9S3 Multiple antibiotic resista... 107 2e-22 1 25.0% 3:214 12:208 --FEHFTLPSFFATFMILFVSIDIIGAIPIALSLKEKGKVFHPSKVA----IISAIMFMAFLFIGEPLLSFFGVDVSSFAVAGSIVLFVLAVEMIFGIQVFQDDDPSGNAD--------IVPLVFPLFAGAASFTAILTMRSSGTANST---LFVAIILNVVCIYLMLRTVSLLERWLGKGGIYILRKFFGVVLLAISVKFFMQNLMIILEPFF-
219 UniRef50_O84860 UPF0056 membrane protein CT... 105 1e-21 1 21.2% 8:210 2:196 -------LHSLFRLTLLFYALFNALGSLPVFIALLKNFSFKKQQHIILRESIFALLLLLLFVTFGRGFFRLLGIILPAFQFTGSLLLGSIAIDMMKALP------PQTETLERDKDEPIFFPLAFPVITGPAMITS--TLGHMEEGIFPKKIVLGAIVLAWLFSLITLLLSSSINRLFGQMGLLALERLFGISLALMAGNLMLKALSTAF-----
220 UniRef50_Q607N5 MarC family integral membra... 105 1e-21 1 24.8% 10:211 2:194 ---------TLAQVAVLLFLITDPFGNLPLLLTVLQRLGHAAYLRAVLRETAIAFVVLVVFAWKGDLLLGYLNVTQPSLNIAGGVILTIISLKMIFGG-------AQETFDDRYANDPLVVPIAIPAIAGPAALTTVMLLSKQQGIPFPTL--FTALTLVFLANLTTFLLGRLLGEWLGPRGLTALERLMGLLLNLVAVDMTMAGIKRFFT----
221 UniRef50_UPI000038253B COG2095: Multiple antibioti... 105 2e-21 1 26.7% 8:168 11:173 -------LTSFLLALSGLFSIVNPVGSALIFAQVTATRSQGERAELSRRIGFYAALVMLAALWAGAPILNFFGVSLAALRIAGGLFVAASAWTLLSAPETREARKHAEAAPeeNLAEIAFFPLTLPFTTGPGTIAVAIALGANRPSEPADLAAFFVGASLAALAIAGM-----------------------------------------------
222 UniRef50_D2ASF4 Putative uncharacterized pr... 104 3e-21 1 21.1% 12:215 6:220 -----------LILFLALFGLYSPVAALASYLPIVRPYSHGQVNRLALGLAFNVAVFVLAALWVGEPLLKLLGISTAALTATGGIALAYASIPLMRGKAGAVEELEkpTEPAPDPKSILYTPLTFPLTVGGTTFAFGVAASASAAGTQDKIALSIAALCFAAVTGLTLYLSGHVQRRISLKGAMLLDRVAGILLTAIAVILLANGFTDLVTDRLN
223 UniRef50_C9L1U4 MarC family integral membra... 102 1e-20 1 22.5% 1:213 15:211 IMFTGFNWQQMVSAFIVLFAVI----DIIGSIPIIINLKERGKDVNAMKATVISFVLLIGFFYAGDMMLKLFHVDIESFAVAGAFVIFLMSLEMILDIEIFKNQGP--------IKEATLVPLVFPLLAGAGAFTTLLSLRAEYASVN----IIIALVLNMIWVYFVVSMTGRVERFLGKGGIYIIRKFFGIILLAISVRLFTANITLLIEAL--
224 UniRef50_A1RTR6 Multiple antibiotic resista... 102 1e-20 1 28.1% 6:215 1:197 -----MTPLEFLGLVGQLYAIMNPIGKLAVVGPLAVERPAYVR-KITTVVIAVVYILAAIFAVSGGFILSAFGVSINSFRIAGGIVLMTISVTTLLSGSYVGRIEITE--------EHAVVPLATPLIVGPGTITALIVMSSIYGPLITLFIALTASTAVA----ITLIVGIRAVKYIGATPLRLVGRFMSLIIASVATEMILTGIRNYTQSLCS
225 UniRef50_B5IJ45 Putative membrane efflux pr... 100 2e-20 1 22.1% 8:211 1:200 -------MEDLNRSVITLLALINPVICAVMLLERTPGVPHRRRLLLIGNVVLRTGLILLVSAAIGPQLLKRLGISLDVFQIVGGVVITSIGYGMFAPSPAPAAATGQESGSPENASLDPIVLFA----ASPGTISTVLALSVMHGPDQGLLPTSLAVLIALAITAVVMAVMVLRPGASTRSNSSLVSRFLGLILIAMGLQFVLTNLRTFFQ----
226 UniRef50_B8HLY6 Multiple antibiotic resista... 100 3e-20 1 17.9% 9:203 6:202 --------PTLSYVFTIFFLTLGPVKTISAFFRLTREANPKFRQRVALQAALISTAICLFIAFIGHNVLAKWGVSLEALRLAGGLILLLFALKVVMMQPQPSAGVqtADTPLPDTLKLAITPLSTPVIVTPYGVVAILFYMVIAQGYAVlvQILGIVFLIMLLNYLGMIFADKIMNIIGMPILQLIGWIFAVMQSALAIDIML------------
227 UniRef50_Q4C088 Multiple antibiotic resista... 100 3e-20 1 21.0% 13:207 81:274 ------------RLTIILFMTIGPIKIIPVFARLTQNASKQVIIKLATRSFALSTLSILTVALASENILNKYIISLSSLIVAAGIVLFLISLKMLLQQYDNQKNNPLPIPE--NPLTALISPLTFPTILTPQGIALVMISMTIAQRLDNNVdiLGLIMVVMILNLLSMLDARQILTVLQPILLQILNLILSIIQLALAISFMFSGIT--------
228 UniRef50_B3ET88 Putative uncharacterized pr... 100 3e-20 1 23.7% 2:199 7:188 -FFIAFNIKKFLTAFFILFAVIDVLGCTAIIINMRNKIGYIH----ARKTATVAGVIMVTFLFLGQTILDLFSIDMSSFIIAGSIILFLLGLEMCLNISIFKTDT--------DANSSSIVPLAFPIIAGTGTLSTLLILRAECETIN----VLLASLVNLVLIFLVLKYSEWIEAKLGRLGVSIIHKMMGIILIAIAI----------------
229 UniRef50_UPI0001699175 multiple antibiotic resista... 100 4e-20 1 24.3% 10:182 8:171 ---------EILSIAITLFLIMDPFGNIPVFLSILARVTEERRRVVLARELLLALVVILLFVFFGGTVMSLFGLSRAAVTIASGAILFLIALRLVFP-------EKEAAADDEFEDEPLLVPLAVPLIAGPSLLAVLLVFTATEPDARGTLLIAALLAWLATST--ILLASTFLYRVFSPCG---------------------------------
230 UniRef50_B3T2F3 Putative MarC family integr... 100 4e-20 1 26.8% 58:210 1:155 ---------------------------------------------------------MITFAYAGRYLLDAIGVSLDSLKIAGGIILMILAIDILFEKRKTRREKreEALDEKSFDDIIVFPIAIPFIAGPAALTTIILLIGNYtnTEFQIPVILALIAALVVSLILMIGANFIVKFLPKQILHATARVMAFILAALATQFIIDGIKASF-----
231 UniRef50_C6HYD3 Multiple antibiotic resista... 99 9e-20 1 20.2% 8:210 1:196 -------MHTFWSVFLPLFVAIDPPGVLSIFFSLTQGVDIAQKRRTARSAVLTASLTVLFFDVFGTRLLDFLGLTLWDFTLA---GGLLLLVLSVSDLLKNQDPETAGRPPGPFIGTLGPVPLGIPIIAGPATLTTSLIASKSASLAWALTALAA----NMAILLAVLLAADRITRLLGAPLSAAVGKIFSLLLAAIAIHLIHRGIDGLL-----
232 UniRef50_D0SM32 MarC family integral membra... 99 9e-20 1 20.0% 8:212 2:203 -------FSPYIHAFALFFSLLNPFLMSVYMIGMIRNTDAKVFSKALIQGCLIAFIVFILFAWGGESIfrYLNVRFESFQIFGGLIFLVIGYRYVFQGAETIGEMRGAPEHLAGT-------IAMPFMIGPGTISAAVVTGISVPFSGAVAVIAITLMLTCSILILMKFAHDHlhAKYIDRYFDIVGRLSALLIGTIAVDMIVNGIMGLIES---
233 UniRef50_D0ZDR8 Membrane efflux protein n=1... 99 1e-19 1 16.5% 8:213 5:211 -------LIHFLLTYVTFLSMFCPPATITAATILLGQTPPHTLRQLAWKVALEYVAVMLVAIWIGNYLLMALGLNAHALTATGGAALLFQGWpmTKGTKAEPARMVVTPDARPNVQDMVLVPLLFPLTIGGGTIAVGISLASHDGSLAGLLQLSAVILLMAPTIALTFLAVGPLHGRLSSGAIDAMARIAGIVLVTLSLQLLASGLTQLVLQY--
234 UniRef50_C7LK11 MarC family integral membra... 99 1e-19 1 21.2% 1:212 1:197 MHEKLQQIKLFFTCFLILFSIIDIIGNAPIIIGYKKKGNIINTKKI----TLVSMLIFLFFFFLGDFFLNSFGIDLYSFSLAGSIILFLVSLEMIFEIDFSKLEKKSNI-------EISIIPISFPLIAGPGSVTTLMSLKTNY----DIKTIMLSLILNMIFVFFVIKNIDFIEKKISKSNLYIIKKLFGIILLSFSIKVFGRNVCNIFPN---
235 UniRef50_A8Z5R7 MarC family integral membra... 99 1e-19 1 21.5% 16:210 1:180 ---------------MVLFSIIDVIGNAPIIIGYKNKGDIINPNQV----TLVSLGIFLFFIFLGNFILNTFGIDIYTFSLAGSIILFFISLEMILGIEFYKRDK-------STSAQVSIIPISFPLIAGPGSVTTLMSLKKNY----DMQTILISLILNMIIVFFVIKKIDYIENNISNDNLNIIKKVFGIILLSYSIKLFGRNICNIF-----
236 UniRef50_C6B1S6 Multiple antibiotic resista... 97 3e-19 1 20.1% 1:209 1:206 MDFTVIDAALVGKLLLLLLIGMGPKIALVPFLEKTHAFDTQTKVRIGRQMVMIAVVTALILFATGALLMRLLHITGGAVAVAGGIILALIAIKMASG---PIEKPHDDIAAPVDPDKLAVFPLAVPYLLNPVGITVIIIASGEVVSITSAILVIGLILIVGALDYLVFTNIDKLAKRMKPVTMIVSEVVFGILLTAVAVQLIVVGLGNL------
237 UniRef50_D2PCH4 Multiple antibiotic resista... 97 4e-19 1 25.9% 5:209 1:199 ----MSELVSIPEIAFKLYAIMDPLSILPYLIALYEEFNRNSQNKISwkLSIAVAVLLLFFSILGGPLLAFLGISVSALEIGGGIILVYLGVDTLGGF-------QQLKFLSSKIEEAIITPIATPLIVGPGTMTGLITLSVSNNLIILILGSLLAALLVYLSL----LLGPIIIRVLGNTGTVAVGRFMAIIIAAFGVQLIIDGISQI------
238 UniRef50_B1WP37 Putative uncharacterized pr... 96 1e-18 1 17.9% 13:196 98:279 ------------NIFIIFFVTLGPIKIIPTFIKLTQNADDDLRKSLALNGAGLATIVIVLVVLIGGNILTRWTVSMSALLMAAGIMLFLASLQAVM---SQYKGSAENEPLLEPSMKLLINPLTFPTILPPYGIALALILMVFNNRISDrfIVPVMLILVMMLNLLAMLFARPILKTIKLPTLRIAGLVLGVMQLA-------------------
239 UniRef50_A2SQL2 Multiple antibiotic resista... 94 3e-18 1 24.1% 45:210 3:167 --------------------------------------------RQAFVATGVAGVLMLTFLIFNNLLFDLLGIELESFKVAGGIILFILGLQIVLggGSSAGHKSLESSDRIGKKSMAGVIIGTPVMCGPGTITTVMILGAQ----DGIILTLVAVILALFCIWLILIFSAQIKKLLGETVLVILSKIVGLLLTAIAVHTIWTGILGLI-----
240 UniRef50_A6T440 Multiple antibiotic transpo... 93 6e-18 1 19.1% 9:207 3:198 --------EAYLRSFALFFALFNPFLMSIYLLDLIRGLPTPTFARVLIRGSVISACVFVLFAWGGEAFfdYLQVRFASFQIFGGIVFLLIGLRYVFSGAAAIESLRDNPTAMAGS-------IAMPIMIGPGTVSAAVVIGTRLPLGGAAVVIVGTLILTVSILVAMKVAHDKLKErmTDRYIDLVGRMSALLIGTIAIDMILTGLQ--------
241 UniRef50_D0SWE6 MarC family integral membra... 92 2e-17 1 20.5% 8:212 1:202 -------MSESLNAFALFFSLLNPFLMSIYMLGIIRNSDAKVFNMALIQGSLISFIVFIIFAKTGEAFFnvLHVRFESFQIFGGIIFLVIGYRYVFEGADTIGVMRGAPSHLAGT-------IAMPFMIGPGTISASVITGIQLSLMQTILVIFSTLFLTCSLLILMKYLHDHLQHKYsdLYVDIVGRVAALLIGTIAIDMIVTGVTGILET---
242 UniRef50_A6C262 Putative uncharacterized pr... 91 2e-17 1 19.3% 8:209 1:199 -------MNDVFNSTALLLTLLNPFLVIIYLVDVVQKLEQKQFRHVLMRAGLITSAIFCSFVVLGDKIfgVMQVEFASFQIFGGIVFLLIGIQFVFKGPVVIEALRGESSNISAS-------IAMPVLIGPGTISACVLIGKRHEPLVACTIVVISVFVCLATILVLKFIHDMVNQklIDRYIEIMGRITALYVGTVSIDMIMQGLRTW------
243 UniRef50_C5A3J5 Multiple antibiotic resista... 90 4e-17 1 23.3% 5:210 1:197 ----MSEFSTILSSALLMLIMIDPSDKILLVSFLREDFHIEDIKALIVRANLIGFLLLASFAVAGQIIleIFHIDINALKVAGGFVLFKIGLEALEGGGMFTLKRERDILA------LAAVPVAMPLIAGPAAITAVITLTAEYGYLVSLSATAIAIAVVALSMFVAL----YMMKSVNKTFLSVTIRIIGLFIMAIGAQMMVEGVVGIY-----
244 UniRef50_Q5WGH6 Putative uncharacterized pr... 90 6e-17 1 22.8% 8:213 2:192 -------VSFFIHAFVSIFAILYPIGNLSVRLGLAHIKGDTQRIHKAAKAILVVLGALTTLLLLEQWLLLLYNISIEAFTIGCGLCLLVIGCKLLQGKTRYRSKQKTI----------------FATVASQGAAGATmlTANQNHRWFYVPITFLAFVSVLVLSLLPLLVANWLRGRTGQKGLSLVKRATGVALTVIAIEMVVMGFADILPSF--
245 UniRef50_A8M8X4 Multiple antibiotic resista... 89 1e-16 1 24.8% 4:213 2:197 ---VAFSLFDSLVAAVQLYAIIDPLGAIPLLVSVPDY--EKMMNKFLRLVAVTVPLLLLLFAFAGPFIFYVFSININDFRVAGGIILLIIAIDVLREGTPKT--------MGINPEDYVIVPIITPMLVGPGAITSVMVMVTYYN----IFSVITAVLIASLATYITMKYSVYLVKLIGNNTLKIFARFFSLIIASWAIQLIASGIINIVKAI--
246 UniRef50_O57953 UPF0056 membrane protein PH... 87 4e-16 1 24.5% 8:215 2:200 -------LKEILSSALLMLIMIDPSDKILLVSLLREDFHIEDVKSLIIRANLIGFILLLLFAVAGKIIldIFHIELDALRVAGGFVLFKIGLEALEGGGMVTIKREKNILA------LAAVPVATPLIAGPAAITAAITLTAEHGIIVSIVGTLIAIAITAALMMIAL----YLMRGISKTALSVTIRIIGLFIMAIGAQMMITGAGGIVLNLIK
247 UniRef50_B4B2T8 Multiple antibiotic resista... 84 2e-15 1 18.8% 8:209 1:201 -------MLKLSSIFILLFITLGPLKTIIPFVELTAHSDEKLCRRVALRATFASTLVVLILGLLGPLILENWGVSLPAVSITGGIILFVGSLQVMM--KPSESSGNKGVAPETLSTSMLISRLVIPTIVTPPGIAAILALMVLSEKNQQLWliIGLLLLVMFLNLLIMLTARKLLAFLTVAGLRVIAWVFAVLQASLGAQVIINALRKL------
248 UniRef50_B2S770 Multiple antibiotic resista... 84 3e-15 1 22.8% 5:210 1:202 ----METGMIVGKLLPLLFNMMGPIGLMPIFAAMTVQMDKPTRNSVAARAAIFAALGILIAIFIGDPILRSWGISKPALILAAGVILTLSSIRAVLMPPAAPSQ----PAAAGDPKALAIRPLAFPTIVSPQGVGVLIIFVAFLSSLSSTITILTVAGVIVLLDYGAMRIAHWFMATVGMVPLLVLGAVFGVLQVALGIEMMLSGLLLVL-----
249 UniRef50_D1BGR1 Cytochrome c biogenesis pro... 82 1e-14 1 20.7% 41:214 121:312 ----------------------------------------ARRKSLRPYLVISGLVVSffFTLLGSLILNALGLPQDLLRWVGLSLLAIIGVGMIVPRLEEIIERPFQRIAAMGARRGsyVPCAGPVLA---AITVA---GATGNIGADTVALTVSFAVGAAIPLLIFALAgrVAERVGakGIRIFGGVT-MILLAIGLAflPQYLQRALPDYT-
250 UniRef50_A8U398 Multiple antibiotic resista... 79 7e-14 1 30.5% 98:215 3:119 -------------------------------------------------------------------------------------------------RSEVDDATATATYGDAQAIKVGVVPLGIPLMAGPGSFTAVI-LESQHSHSGGSLSVSLTIIGVAAVMWVLYLLAVPIARILGPIGLNIITRLFGLVVTAIGVEIIVRGIQTHVASFMS
251 UniRef50_C2CQB7 Integral membrane C family ... 72 1e-11 1 15.2% 2:172 1:175 -MLSTLSIGLVGGLVTGLSPCILPI--LPLVLAVSGNGGRS-RPWLVIGGLVTSFTAVTLFA---TTLLNALHLPGDLVWKVGIGLLVLVGLGMMFPKFQeaKARDKGGFAVGLALGVVFVPCAGPVLA---AISVA---GATGTIDAHILILCLAFAVGVAIPLMAFALGG-------------------------------------------
252 UniRef50_Q0EYM7 Putative uncharacterized pr... 71 3e-11 1 20.4% 30:210 4:182 -----------------------------YLLDLIQDLDRGTFFKVLFRATLISGSVFLVFAWGGDAIfdILQVQFSSFLIFGGIVIFIIALQMMFTGSDAIKKMRGGDPAHLSGS------IAMPFMIGPGTISASVITGTTLSYPLALAAITLSLILT-VLMLMVLKYAFDIIKvlLERYIDITGRASALLTGTIGVQMILQGIHKAL-----
253 UniRef50_D0WLW3 Protein DipZ n=1 Tax=Actino... 71 3e-11 1 19.6% 6:214 1:227 -----MFSQILIGLFGGLITGVSplPMLPifLAGATGASSDGkrKYPLLVTLGLVVSFTAVTLLGSTVLSLLGLPQDFIRWAGVAFLALIGVSLMIPKVEEWLEKPFARIRMKQVDKraYVPCAGPVLA---AISVA---GSTGRVGAETAALAISFAVGVAVPLFFFALAGRgeRIKgrKRQRGIRMAAGGAMIALAAGIVFdrIQRALPDYT-
254 UniRef50_Q12GH3 Multiple antibiotic resista... 70 4e-11 1 19.6% 52:214 60:181 ---------------------------------------------------VTARIVLLIFMVAGDRLLHAMRLTDASFEIAGGVILFLMAMGMAFPG------MGVSLADSGHGGEPMLVPPAIPVITGPSALATVLLLAARQPDRGWTWAAAI-----------------------------------GLLLSAMAVDKLISGLRRAFPGVT-
255 UniRef50_B4V0W4 Integral membrane C-type cy... 70 7e-11 1 23.0% 50:210 166:329 -------------------------------------------------AVVAGLVVSffFTLLGVTIISALGLPQDILRYLGLGLLVMIGLGLILPPVERLLEKprIPQRQVNKEGSAfvPCAGPVLA---AITVA---GARGEISSGIVALTLSFALGTAIPLLVFALAG---RRVSARVAAFRTRARGLRIAA-GTLMIVLAFALAF-----
256 UniRef50_P59960 Protein dipZ n=22 Tax=Actin... 69 1e-10 1 17.2% 11:214 119:354 ----------LVGFLGGLITGISplPVLpiFFSGAQSVDAAqrRKRALSATlvIGGLVLSFglLGSALLSVLHLPQDAIRWAALVALVAIGAGLIFPRFEQLLEKPFSRIPQKqaLGVLYVPCAGPILA------AIVVAGATATIGLGTVVLTATFALGAALPLLFFALAgrIAERVgrRRQREIRIATGSVTILLAVALVFdaLQRAIPDYT-
257 UniRef50_Q255K2 Multiple antibiotic resista... 68 2e-10 1 18.0% 5:210 1:201 ----MDTMYLLFPQACILLLAADALTNVLALNCVLSNYSRKKRLSLLIRESLFALVSMFALYAAALGTLYVLKTPPCAIQVVGGIAVTLAGMRAILNLNRENTWQGFASTSSLS----LVTPIALPLMIGPSWLAacILIGKRYSFTSISLILFLSWALISLTTIILQVFIGVGKEK--TKVLLATQTVLGLFATIVGTQLLMSGLQLAF-----
258 UniRef50_C4XRQ9 Thiol:disulfide interchange... 67 5e-10 1 18.8% 31:195 402:577 ------------------------------LLAISGEEGRQERRRILREHNFFFALGIVTYFLCLSLILGAFGmqSPSLAIVAAVVLFALALSllKITSGGRGHTRRGAFLTGALATLLATPCSGPFLGG-------VLAWTLLQPQHVIMTVFAAIGLGMASPYGVLAIWPRLVRLLPRPgmQSLERVMAFLLA--------------------
259 UniRef50_A7BB75 Putative uncharacterized pr... 65 2e-09 1 15.9% 45:214 80:261 --------------------------------------------SVTRRPVLIVLGLVTSFmvAGSALLSLLNLPQALIRWTGIVLLMAVGIGMIIPKIMEVLERPFTRLAPRTTGdaAFVPCAGPVL------TSIIVASSSGQITWHIVGLAISFAIGVSIPLMIVAIAGsvAARFLKTRQRPLRIAAGVAMIALALGIATdaLQRMIPDYT-
260 UniRef50_Q92Z96 Putative uncharacterized pr... 64 2e-09 1 22.4% 58:209 7:151 ---------------------------------------------------------LAIAGLLGRTMLENFEISLPVLAMTGGIILFLVALRTVLHQSSSLPDQTTEPGQPSDLR-LALTPLAFP------TILAVIVFATLAGGRQAEGRTVAAilLILAMDWAAMIFAESILRWIG-TSLQVLAVVLGVTQAALGLQIILHSLSTV------
261 UniRef50_A6V064 Thiol:disulfide interchange... 62 2e-08 1 17.8% 47:203 354:514 ----------------------------------------------AVLVCLALGAVLMALRALGSEIGWAFQLQNPAVILL--LILLTSAMGLNLAGLFELGSLSAGSRLAGQDGPAGAfpCSGPFMAG--ALGAALVL-----PPLAGLLVFAGLGFGLALPFLLLSFAPVLQGWLPRPgmQTLRRVLAILLFASAVWLVW------------
262 UniRef50_D1K837 MarC family integral membra... 54 3e-06 1 24.3% 53:122 9:78 ----------------------------------------------------ISFITLLAFTFSGQFLFKFFSISTNNFRIAASFIILKIGYDMLQARFTNTKLKNKEIKTYANDIPSLRFP---------------------------------------------------------------------------------------------
263 UniRef50_A6FJM2 Putative uncharacterized pr... 49 1e-04 1 25.8% 8:73 5:70 -------FEHALTVFMAFFAIMNPIANTTVFAGLTGSMGKSEQVKIAVKSLTITFVIIVLFSILGKSIFHLFG----------------------------------------------------------------------------------------------------------------------------------------------
264 UniRef50_Q8ZY52 Putative uncharacterized pr... 46 8e-04 1 29.5% 6:83 1:77 -----MTPLEFLGLVGQLYAIMNPIGKLAIVGPLAVEKPTYVR-KITVVVIIAVYILSLIFALSGGLILAAFGVSLDSFRIAG------------------------------------------------------------------------------------------------------------------------------------
265 UniRef50_C8RVH9 Integral membrane C-type cy... 50 5e-05 1 17.3% 1:214 1:224 MGWDIALIGVIGGLVTGLSPCILPV--LPIVLAVSAD-----KRRKPWLVATGIGLSFTLVTLLGTLILSALGLPKDLLRWAGVVLLVLVGVSMLWPALGDQLERPFARIRIPGWIQraVypCAGPVLA------AVTVAGATGQIGWGSVVLAVSFAVGACTPLFFFALAG---KQIGTRADFviSYGAGALVIVLAVAIAFnaLQRALPDWT-
266 UniRef50_C9LAL7 Cytochrome c-type biogenesi... 49 1e-04 1 21.6% 8:215 12:241 -------LTVFLQGLLSFfpCVLPL--IPLYISYLSGGTQtkRRKVMLNTLCFVIGISFAFFLLgsAIGTFFQSNQLLFARIGGILVVLFGL-YQLGVLGTSRILGQERRLPFKLDVLAMSPITALImvGP-ALTSVLLMAASASTKLWGFLLIGVYTIGFVLPFLAvlFTTKLLEFFKAHVKVvtAKIGGVLMIFMGI-LMFTGKMNAVTGYLS
267 UniRef50_A2V4T5 Putative uncharacterized pr... 47 4e-04 1 32.5% 173:212 29:68 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------PICKFMGKTGIDALTRIMGFLLVSMGMQFMINAVKDLLTD---
268 UniRef50_D1QRG2 Putative thiol:disulfide in... 47 6e-04 1 21.8% 4:205 244:460 ---YIFLMGFLGGLLALFTPCVWPI--IPMTVSFFLKRAKDDRRKGIRDAITYGISIIVIYLILGLAVTRIFGASapFFNIIFFLMLVVFALS-FFgkLPEKWGNAVDTKASSTTGLLSIFLMAFTLttGP-IIGFLLVASTTSGSLLGPAFGMLGFAVALALPFTLFAMFPSWLKSAPKSgmNTIKIVLGFIELAFSLKFFSTA----------
269 UniRef50_B4S463 Thiol-disulfide interchange... 46 8e-04 1 15.0% 2:201 288:501 -LGAMLFLAFFGGMLLNIMPCVLPVLGLKVFSLIGPGGDRAAGRFLSLvgVLFSFWVLAAFIwmGAQVGWGFQFQSPAFVMFMAAVVFAFALNlvFEFSAPVVSGRLGRLASHHDSAGAFvtLATPCTAP--FLGTALGF-AFAQPPGIIFLIFTVIAAGMAMPYVVLAWHPSWLKFLPRPgmYRFKQIMGFILVAVVVWL--------------
270 UniRef50_C6JNU9 Cytochrome C biogenesis pro... 45 0.001 1 13.4% 5:206 8:231 ----TDNISFILVFLGGIFSFFSpiPLLPVYMSYLSGNTAVtqKKVFIHTIFFILGISAAFFILgsKLGGFFNTNRVLfrISGALILLLGLFQIGLLKSSFMERERRINFDSKKINPLIAFVIGFTFsiGP-VLSTVLIMASGAKTSFLGNMLILVYSLGFIIPFLLliFTTKVLNFlkKSFLKYSIKISGAILIIIGI-MTLSGF---------
271 UniRef50_C0GSU1 Cytochrome c biogenesis pro... 45 0.002 1 18.1% 31:196 254:431 ------------------------------MLTLEEDSGIDAQKRAFRKHNIFFALGMLIFFSVLAVVLSLTGMagQLFQSPGAILVliFALSllFgtRDPWKNPNAEALSTGMLATFLATPCSGPFLGG-------VLAWTLTQPPAIIGIVLWSMGLGMALPYLLMAVFPFMLRFLPRPgtMYLEKILGFFLLA-------------------
272 UniRef50_B2TCS6 Cytochrome c biogenesis pro... 45 0.002 1 13.6% 14:204 334:506 -------------ALATALGIVTSFGLLAAVLSILKLAGASLGWGIQFQQPWFLAGMAVVTTLFAASFFDWLPIGLPPF-LSGG------------ASGATNRGPLVEAFLGGMLSTLLATPCSAPLV------GTVVGF-ALARRPLEITAVLLALGVGMALPFLTLVLAPSLATRLPRPgmIQLRKIMGLLLLTTSIWLIAS-----------
273 UniRef50_B6WR88 Putative uncharacterized pr... 44 0.005 1 21.9% 85:198 337:454 ------------------------------------------------------------------------------------MLVFLMGLSMllKAGANSKNPRLQPYLTGLVSTFLATPCSGPLLGG-------VLGWAFTQPLLVLMVVFWAVGLGMALPYILFSIWPQLARILPRPgmKVFERILGFCLLGTA-----------------
274 UniRef50_A6LIG5 Thiol:disulfide interchange... 43 0.007 1 19.0% 8:202 243:455 -------FIFFAGFLGGLIALLTppMTVSFFLKRTKD-----RKKAIRDAITYGLSIIVIYLVMGLLITGIFglSTNafNILFFLLlfFGAFELVLPASWTSKL---DSKADSTTGVLSIFFMSFTLvtGP-IIGTLLVQAASMGTAVGPAIGMFGFALALSIPFSVFAIFPNMLQSMPKSglNSVKVVLGFLELALALKFL-------------
275 UniRef50_D2R0A7 Cytochrome c biogenesis pro... 43 0.007 1 15.9% 8:214 456:675 -------LAFLGGLILNLMPCVLPVLGLKI-LSFAKQGGQSRSKVILLNVAYTAGLLSVFLVLAALVAFANMgfTQLWFRVTVTAIVFVMSLSFlfATSEKASeqSQEGVQGAYYKGIFTTVIATPC-SGPF-LGTVLGLTLDQP-IPAIFMIFTMAGLGMASPYLLVGLFPQLSRVIPKPgmETFERLLGFllLAAVVQFSTIGAEHYTAALM-
276 UniRef50_A5EVX1 Thiol:disulfide interchange... 43 0.009 1 16.4% 27:203 233:422 --------------------------MIPIVTSFVVGKNASFARGQLL-ITAYVLAMASTMALLG-AVFGLFQINLQVvaIASAivLTLSAPQRMQHWVDRFSQKQTRgaIVLGALSVLVvpCATPVL------TALLLYTTQTTPFKGALALFC-LGLGMGLPL--FLFASVFRRFMPKAgmLIIKRLLALMMLAIAVWLFA------------
277 UniRef50_D1RKA5 Cytochrome c biogenesis pro... 43 0.009 1 17.1% 8:206 6:221 -------INIILGFIEGFGLIISplPILPIFLA--GSLTGSKKRPVGIIIGFTLFFSLLVF--FSHQLVQYFDIDFNWVRDFGYAVLLILGVIMlfGKMTQGFTRIGNFFSKANNTeiAitPCAGPILA------AIIVQTALQKATLVSFLTLMAFALGATIP--MFIISLYGKKLIgkTKAILFRKFLGGLIIASVVYMlfEGI---------
278 UniRef50_A3VPJ2 Thio:disulfide interchange ... 42 0.010 1 14.5% 38:203 371:552 -------------------------------------LSREERPTIRRHGLLYTAGVLTTFgaAGEGLGWGFHLQSpaVGIFA-VILFLVALNLlsVQGTGDQLTKKPGAAGAFFTGVLAvpCIGPFLGG----ATGLALAA---DPVIGLVIFLSIGLGLALPYLGLSFVPKAVRVLPRPgmVILRQLFSFALFAALVWLIW------------
279 UniRef50_C7LW03 Cytochrome c biogenesis pro... 42 0.010 1 17.5% 31:196 240:416 ------------------------------FIPAADSVPKSQRHAFRTHNLFFALGMMLYFLVL-AGIIAVTGmqEPAAIITLTAIVFALSLSllKGKAKGVVHHPreSFTTGILATILATPCSGPFLGG-------VLAWALIQPPDIIALVLSCIGLGMASPYLAMSLFPGLYRFLPKPgtLHLERILGFLLAA-------------------
280 UniRef50_D1U524 Cytochrome c biogenesis pro... 42 0.012 1 16.1% 47:207 295:455 ----------------------------------------------ALGVIAFFMLLAAVLGVTGQAWGALFQNQWLVLAVAGVILVLSLSLFGLFHLPikSASPRVQAFFTGNLTTLLATPCSGPFLGG-------VLSWSLVQGPAVIATVFASIGLGMASPYLLMALNPRLSRFLPRSgiAYVEKSIAFFL--IGTAFYLVGIA--------
281 UniRef50_C3QTX5 Thiol:disulfide interchange... 42 0.012 1 18.2% 11:202 206:412 ----------FLGGLLALfpCVWPIIPMTVSFFLKRNKDKKKGIRDAWtvVIYVTLGLAITLIFGASALNALS-TNAVFNILFFLMLVVFafGAFELTLPSKWSNAVDSKAEATSGLLSIFLMAFTLstGP-IIGFLLVQVSTTGSVIAPAIGMLGFAIALALPFTLFALFPSWLKSMPKSgmNVIKVILGFLELAFALKFL-------------
282 UniRef50_C1YPQ2 Putative uncharacterized pr... 42 0.014 1 16.2% 54:158 13:109 -----------------------------------------------------APLALQSFETSGNNLLGY---------VAggVILGVLALIIIGGRMIHANFTGDPWIAARGMAELPYVVLAVVLIAGSGSLTAMLFEGSLHHPEEDVSTSIRALV---------------------------------------------------------
283 UniRef50_A8RWY3 Putative uncharacterized pr... 41 0.022 1 19.0% 8:212 12:205 -------LTVFIQGLVSFfpCVLPL--IPLYIGYLSGGTGkeRSKVMLHTLCFVIGVSFAFFLLgsTLGTFFKSNQLLFARVGGILVVLFGF-YQLGFFGKSGAMGKEHRLPFKLDMLAMSP-----------ITALIMGFTFSFAWTPCVGPALASVLLMAASASTKALA------FGLIGVYTL----GFVLPFLAVGLFTTSLLEFFKT---
284 UniRef50_B2RHT5 Thiol-disulfide interchange... 41 0.024 1 21.5% 8:202 232:441 -------LYGFLYGFVALlpCVWP--MIPMTVSFFLKRN-KDKKKAVRDAFTYGASIIVIYVVLGLLITGIFGvtNAVFNIIFFLLLVVFAISFFGAFepSSWTNKLDSKADSTTGLLSIFFMAFTLatGP-IIGTLLVQAATAGSKLAPAMGMLGFATSLALPFTLFAVFPSWLQGMPKSglNMVKVVLGFLELALALKFL-------------
285 UniRef50_A0RPW5 Thiol:disulfide interchange... 41 0.029 1 17.7% 5:202 176:388 ----LFTIITFFGYGLLLSLTPCIFPMIPIVSSivSKTGQKPSAKTGFWISLVYVFFMSLAYALAGVLASVFglQIPSVIIGFSIIFVLLSFSmmPKKIQNYINLKSEKKGGIIGVGIMGFLSA--LIVGpaPLAGALLYIAESGDALFGGIALFVMSVGMGVPLLLIGIGS--SKLLPKPgmEEIKRIFGFLMLAMAIWML-------------
286 UniRef50_A6G157 Putative exported cytochrom... 40 0.048 1 22.7% 8:95 206:303 -------FQFLVGSFIalLALLTpfPMIPITISFFAKHAEASRKKSLIMAGTYSGAIVVCFTILgsVIFGASAMQQTafNIFMFLLLFVFGLSLI------------------------------------------------------------------------------------------------------------------------
287 UniRef50_Q7UH35 Predicted cation efflux sys... 40 0.050 1 16.3% 46:174 390:518 ---------------------------------------------MGWRSALIVTLTLPLASLMVLFGLRVVGIPIHQMSITGLIIALGLLIDNAIVVVDEVQARLRSGMSPSNAMTSSVSHLAIPLLG--STLTTALAFaaLMPGPAGEFVGSIAISVIMAITSSLFLALTVI-----------------------------------------
288 UniRef50_D0KYJ7 Cytochrome c biogenesis pro... 40 0.079 1 12.2% 2:214 382:609 -LQTGSLWTIILGfvIGLLLAFTpfPMIPILAGIIAGQGDKITTRKAFVLSVVYVLAMAVTYTVAGILAGLFGSNLQalTAFAGVFIAL-AFSmlPSSLQSKIMQVQNNQQGGTLVGVAIMGLLSALIVGppPLAGALIYIGQTGDAVLGGTALFAMSIGMGLPLII--VGTLGGKFLPRAgmDAVKNVFGVLMLGVAIWM----LERIIPDIV-
289 UniRef50_C8N8F9 DsbD family thiol:disulfide... 39 0.080 1 12.8% 16:202 330:527 ---------------VSFTACVYPL--VPIVTSLVVGKNTSSARAY-RLISVYVLAMGAAMGLLG-AVFGIFQINLQViwITVLVALLFAGLSllQKPVDKLNRKQqtGAAAMGALSILVvpCATPIL------TALLLFTTQTTPLKGATAL---FFFGLGTGLPLLLFAGAFRKFLPKAgmDNVKKGFAFALLAIATWLI-------------
290 UniRef50_A6DGV9 Thiol:disulfide interchange... 39 0.085 1 15.8% 2:204 297:512 -FFITIAYMFIGGLLLNLMPCVFPVLALKifL----NQSSEGKGSALKHGLAYSSGVLMSFWVLSLVIIIlfQLQDPAFVLGMVVLLFVIALnlTGAGQKVKKEGAGGSFMSGVLATVVATPCAGPFLG--VALAATFSMSS-----FPLLLSFTAMGLGLSFPYLILGVKPELLKFLPRPGAW-MERfmGFLMLLAVVYFFWT-----------
consensus/100% .......................................................................................................................................................................................................................
consensus/90% ................h..h........hh..h..t..........h...h..hhhhhh.hhhG..hhthhtlt...hthsushllhhhuhthh........................hhPhshPhhhus..hs.hh.h.t............h.hhh..hh.hhhh.....h.thh...h..hh.ph.uhhh..huh.hh.............
consensus/80% ......hh..hh.hh.hhsPh..hshhhshhtt.s.t.p.thhh...hhshhhhhhhhhhGt.lhthhslsh.shpluGGlllhhhuhphh.....................t..hhPluhPhhsGPuslsshhhh.tt.......hhhhhshhhhhhh.hhhhhhu..l.phls..sh.hht+lhuhllhsluhphhhtuh..h.....
consensus/70% ..h..hh.hhhhlhslhsPhu.hshahshstths.tpppphshpsshhshhlhhhhhhhGphlhphhulshsuhpluGGlllhhhuhphl.st.tt.t.t.tt.....t.tphuhhPluhPhlsGPuslsshlhhtsphtth.thhhhhhuhhhshhhshhhhhhuthl.chlGttuhthlp+lhGhllhslulphhhsGl.thh...
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown